1-MPS | LOWER BASOPHIL COUNT AFTER ANTI-THYMOCYTE GLOBULIN INDUCTION IS ASSOCIATED WITH A LOWER INCIDENCE OF CARDIAC ALLOGRAFT REJECTION | Bosko Skoric | Received |
1-MPS | TRANSPLANT RECIPIENT OUTCOMES WITH EXTENDED CRITERIA DONORS: AN ANALYSIS OF THE GUARDIAN HEART REGISTRY | Andreas Zuckermann | Received |
1-MPS | LEFT VENTRICULAR ASSIST DEVICES AS BRIDGE-TO-TRANSPLANTATION IN A LOW ORGAN DONOR ENVIRONMENT | Dimitris Miliopoulos | Received |
1-MPS | INITIAL EXPERIENCE WITH LOCAL LABORATORY RUN ASSAY TO DETECT DONOR-DERIVED CELL FREE DNA FOR NONINVASIVE DIAGNOSIS OF ACUTE MYOCARDIAL REJECTION | Stefania Manno | Received |
1-MPS | VALIDATION OF THE 2014 CONSENSUS PRIMARY GRAFT DYSFUNCTION DEFINITION USING THE GUARDIAN-HEART REGISTRY | Andrea Eixeres Esteve | Received |
1-MPS | INFLAMMATION IN BRAIN DEATH DONORS PROTECTS TO PRIMARY GRAFT DYSFUNCTION IN HEART TRANSPLANTATION | Gabriel Moreno-Gonzalez | Received |
1-MPS | LOCAL LABORATORY-RUN DONOR-DERIVED CELL-FREE DNA TESTING IN STABLE HEART TRANSPLANTATION: TWO-CENTRE EUROPEAN FEASIBILITY STUDY | Tímea Teszák | Received |
1-MPS | LIVER AFTER HEART AND COMBINED HEART LIVER TRANSPLANTATION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: A CROATIAN EXPERIENCE | Maja Sremac | Received |
1-LBP | EXPLORING PERSPECTIVES ABOUT THE PSYCHOSOCIAL FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION AND TRANSPLANT OUTCOMES FOR CHILDREN | Ji Soo Kim | Received |
1-P | HOW COVID-19 PANDEMY INFLUENCED ON QUALIFICATION FOR KIDNEY TRANSPLANTATION IN POLAND | Jacek Zawierucha | Received |
1-MPS | HEART TRANSPLANTATION IN ADULTS WITH PERIPARTUM CARDIOMYOPATHY | Nadegda Koloskova | Received |
2-MPS | LATE OPPORTUNISTIC INFECTIONS AFTER KIDNEY TRANSPLANTATION IN THE ERA OF CONTEMPORARY IMMUNOSUPPRESSION: ROOM FOR IMPROVEMENT | Marie Matignon | Received |
2-P | HIGH CLASS II EPLETS MISMATCH WITH VARIABILITY- / LOW- OF TACROLIMUS LEVEL ARE ASSOCIATED WITH THE DEVELOPMENT OF DN DSA AND POOR GRAFT OUTCOMES | Dong Ryeol Lee | Received |
2-MPS | OUTCOME OF KIDNEY TRANSPLANTS FROM VIREMIC AND NON-VIREMIC HEPATITIS C VIRUS POSITIVE DONORS INTO NEGATIVE RECIPIENTS: RESULTS OF THE SPANISH REGISTRY | Antonio Franco | Received |
2-LBP | THE RISK OF MICROBIAL INFECTION IN RECIPIENTS OF DONOR LIVERS THAT UNDERWENT HYPOTHERMIC OR NORMOTHERMIC MACHINE PERFUSION | Bianca Lascaris | Received |
2-MPS | KIDNEY TRANSPLANTATION FROM DECEASED DONORS WITH BACTEREMIA | Maria Darema | Received |
2-MPS | ADVANTAGES OF MONITORING CELLULAR IMMUNE RESPONSE AGAINST CYTOMEGALOVIRUS IN RENAL TRANSPLANTATION. | Javier Arias Alcalá | Received |
2-MPS | THE COST-EFFECTIVENESS OF PROPHYLAXIS IN CYTOMEGALOVIRUS SEROPOSITIVE (CMV R) KIDNEY TRANSPLANT RECIPIENTS OVER THE FIRST YEAR POST-TRANSPLANTATION | Villeneuve Claire | Received |
2-MPS | LONG-TERM IMMUNE DYSREGULATION AFTER RITUXIMAB INDUCTION IN ABO INCOMPATIBLE LIVING-DONOR RENAL TRANSPLANTATION - IMPACT ON CHRONIC BK VIRUS INFECTION | Rolf Weimer | Received |
2-MPS | BKEVER STUDY: BKV CLEARANCE IN KIDNEY TRANSPLANT RECIPIENTS AFTER REPLACEMENT OF MMF BY EVEROLIMUS AND REDUCTION OF IMMUNOSUPPRESSION | Sophie Caillard | Received |
2-MPS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN KIDNEY TRANSPLANT RECIPIENTS : A RETROSPECTIVE MULTICENTER NATIONWIDE COHORT STUDY | adelaide Sanson | Received |
2-MPS | COMPASSIONATE USE PROGRAMME OF MARIBAVIR FOR ADULT PATIENTS WITH POST-TRANSPLANT REFRACTORY CMV INFECTION | Michčle Maric | Received |
3-MPS | SERONEGATIVE TRANSPLANT PATIENTS REMAIN AT SIGNIFICANT RISK OF SARS-COV-2 INFECTION AND COMPLICATIONS; WE ARE NOT OUT OF THE WOODS YET | Laszlo Szabo | Received |
3-MPS | THE IMPACT OF MONOCLONAL ANTIBODY AGAINST SARS-COV2 AND VACCINATION ON OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS WITH COVID-19 | Bruce Gelb | Received |
3-MPS | THE IMPACT OF EARLY THERAPIES FOR COVID IN A GROUP OF KIDNEY TRANSPLANT PATIENTS | Elena Conto | Received |
3-MPS | INCIDENCE AND SEVERITY OF COVID-19 IN RELATION TO ANTI-RBD IGG ANTIBODY LEVEL AFTER COVID-19 VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS | Céline Imhof | Received |
3-MPS | REPEATED COVID-19 VACCINATION ENHANCES MEMORY T-CELL IL-21 AND MEMORY B-CELL RESPONSES IN IMMUNOCOMPROMISED KIDNEY TRANSPLANT RECIPIENTS | Reshwan Malahe | Received |
3-P | IMPACT OF DIFFERENT IMMUNOSUPPRESSIVE PROTOCOLS ON CLINICAL OUTCOMES IN OBESE KIDNEY TRANSPLANT RECIPIENTS: A PROPENSITY SCORE MATCHED ANALYSIS | Lina Maria Serna Higuita | Received |
3-MPS | REPEATED COVID-19 VACCINATION OF IMMUNOCOMPROMISED KIDNEY TRANSPLANT RECIPIENTS LEADS TO THE INDUCTION OF A FUNCTIONAL T CELL SUBSET ASSOCIATED WITH ANTIBODY PRODUCTION | Yvette den Hartog | Received |
3-LBP | PERFUSION PRESSURES, INTRAHEPATIC PERIVASCULAR EDEMA, AND PARADOXICAL WEIGHT LOSS DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN DONOR LIVERS | Bianca Lascaris | Received |
3-MPS | SAFETY AND EFFICACY OF TIXAGEVIMAB/CILGAVIMAB FOR PRE-EXPOSURE PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY | Simona Simone | Received |
3-MPS | SARS-COV-2 ANTIBODIES RESPONSE AFTER VACCINATIONS IN KOREAN KIDNEY TRANSPLANT RECIPIENTS | Kina Kim | Received |
3-MPS | TH1-DOMINANT CYTOKINE RESPONSES IN KIDNEY PATIENTS AFTER COVID-19 MRNA-1273 VACCINATION ARE ASSOCIATED WITH POOR HUMORAL RESPONSES | Yvette den Hartog | Received |
3-MPS | REAL-WORD EXPERIENCE OF SOTROVIMAB TO PREVENT SEVERE COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM A NATIONAL STUDY | Marie Matignon | Received |
4-P | PANCREAS TRANSPLANT ALONE IN UREMIC (PTAU) PATIENTS | Yi-Ming Shyr | Received |
4-MPS | ISLET ISOLATION AFTER NORMOTHERMIC MACHINE PERFUSION OF DISCARDED HUMAN PANCREAS. A PROOF OF CONCEPT STUDY. | Catherine Parmentier | Received |
4-MPS | EFFECT OF RECIPIENT BODY MASS INDEX ON OUTCOME OF PANCREAS TRANSPLANTATION: A SINGLE-CENTER 20-YEAR EXPERIENCE | Samrat Ray | Received |
4-MPS | 40TH ANNIVERSARY OF PANCREAS TRANSPLANTATION IN SPAIN. LESSONS LEARNED AFTER MORE THAN 650 CASES IN A SINGLE CENTER | Joana Ferrer-Fŕbrega | Received |
4-MPS | CONTINUOUS VS DISCONTINUOUS HUMAN ISLET PURIFICATION: A MATCHED DONOR COMPARISON. | Antoine Buemi | Received |
4-LBP | QUALITY OF LIFE OF LIVING KIDNEY DONORS AT CHO RAY HOSPITAL:THE SHORT-FORM 36-ITEM HEALTH QUESTIONNAIRE SURVEY | CHUAN HOANG | Received |
4-MPS | RETRANSPLANTATION AFTER PANCREAS GRAFT FAILURE IS IT A VIABLE OPTION FOR SELECTED CANDIDATES? | Lucrezia Furian | Received |
4-MPS | EARLY RELAPAROTOMY NEED AND RISK FACTORS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Bruno José Fraga Dias | Received |
4-MPS | NORMOTHERMIC EX SITU PANCREAS PERFUSION FOR THE PRESERVATION OF PORCINE PANCREAS GRAFTS | Laura Mazilescu | Received |
4-MPS | USING DIABETES TECHNOLOGY TO MANAGE HYPERGLYCAEMIA IN PEOPLE WITH TYPE 1 DIABETES AND FAILING PANCREAS TRANSPLANT | Thomas Johnston | Received |
5-LBP | HEPATIC ARTERY COMPLICATIONS AFTER LIVER TRANSPLANTATION IN CHILDREN | Arianna Trizzino | Received |
5-MPS | THE MORBIDITY BURDEN AFTER LIVER TRANSPLANTATION A TREATMENT-BASED ANALYSIS | Joris COUILLEROT | Received |
5-MPS | FACTORS AFFECTING SIGNIFICANT DIFFERENCE BETWEEN RADIAL AND FEMORAL ARTERIAL BLOOD PRESSURE IN LIVING DONOR LIVER TRANSPLANTATION | Hyun Ji Hwang | Received |
5-MPS | BILIARY COMPLICATIONS FOR HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) AND UNIVERSITY OF WISCONSIN (UW) PRESERVED DECEASED DONOR LIVER GRAFTS | Gianna Fernandez | Received |
5-MPS | IMPACT OF DUAL HYPOTHERMIC OXYGENATED MACHINE PERFUSION (D-HOPE) ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION | Damiano Patrono | Received |
5-MPS | INDIVIDUALIZED HBIG WITHDRAWAL IN AN HISTORICAL COHORT OF LIVER TRANSPLANT RECIPIENTS IN ITALY. | Raffaella Vigano | Received |
5-MPS | EVALUATION THE SIX MONTH ABSTINENCE RULE PRIOR TO LIVER TRANSPLANT: A CLINICAL PRACTICE GUIDELINE | Joanna Dionne | Received |
5-MPS | LIVER TRANSPLANT RECIPIENTS WITH AUTOIMMUNE HEPATITIS IN THE SWISS TRANSPLANT COHORT STUDY HAVE A HIGHER RISK OF GRAFT LOSS AND VASCULAR COMPLICATIONS | Julien Vionnet | Received |
5-P | PANCREAS TRANSPLANT WITH ENTERIC DRAINAGE: EXPERIENCE OF TAIPEI VETERANS GENERAL HOSPITAL | Yi-Ming Shyr | Received |
5-MPS | DO DONOR LIVER BLOOD TESTS PREDICT LIVER TRANSPLANT OUTCOMES? UK NATIONAL COHORT STUDY | Collin Wilson | Received |
6-MPS | REGIONAL OUTCOMES OF PAEDIATRIC RENAL TRANSPLANTATION IN THE UK. A MACHINE LEARNING ANALYSIS:. | Georgios Koufopoulos | Received |
6-MPS | STEROID-BASED VS STEROID-FREE IMMUNOSUPPRESSION IN PAEDIATRIC KIDNEY TRANSPLANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Kavyesh Vivek | Received |
6-LBP | REVERSIBILITY OF DECEASED DONOR KIDNEY INJURY FOLLOWING DONATION AFTER CARDIOPULMONARY RESUSCITATION: A NATION-WIDE POPULATION-BASED COHORT STUDY | Dimitra Limnatitou | Received |
6-MPS | KIDNEY TRANSPLANTATION IN CHILDREN WEIGHING 10 KG OR LESS: IS IT A CHALLENGE? | Ozlem Unlugedik | Received |
6-MPS | CORRELATION BETWEEN CLINICAL OUTCOMES AND QUALITY OF LIFE IN PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS. | Jelena Stojanovic | Received |
6-MPS | BASILIXIMAB VS ANTI-THYMOCYTE/ANTI-LYMPHOCYTE GLOBULINS IN PEDIATRIC KIDNEY TRANSPLANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Mikhail Nozdrin | Received |
6-MPS | EFFECT OF DONOR TYPE ON GRAFT AND PATIENT SURVIVAL IN PAEDIATRIC RECIPIENTS OF KIDNEY AND LIVER TRANSPLANTATION. | Mikhail Nozdrin | Received |
6-MPS | SYSTEMATIC DIGITAL ASSESSMENT OF PATIENT-REPORTED OUTCOMES IN CLINICAL FOLLOW-UP OF PEDIATRIC KIDNEY TRANSPLANTATION PATIENTS: A PILOT STUDY. | Fabian Eibensteiner | Received |
6-MPS | DONOR-DERIVED CELL-FREE DNA (DD-CFDNA) AS A NON-INVASIVE BIOMARKER OF KIDNEY ALLOGRAFT REJECTION IN PEDIATRIC KIDNEY TRANSPLANTATION. | Julien Hogan | Received |
6-MPS | THE EFFECT OF HLA MISMATCHES ON POST-TRANSPLANT OUTCOMES IN PAEDIATRIC RENAL TRANSPLANTATION | Vivek Kavyesh | Received |
6-MPS | RENAL ALLOGRAFT SURVIVAL FOR (RE)TRANSPLANTED CHILDREN IN ADULTHOOD; AN ERA REGISTRY STUDY FROM 1978 TO 2019. | Evgenia Preka | Received |
7-LBP | ISCHEMIC PRECONDITIONING AMELIORATES MOUSE RENAL ISCHEMIA-REPERFUSION INJURY THROUGH ACTIVATING THE NRF2/HO-1 PATHWAY ENHANCED AUTOPHAGY | Eun Sil Koh | Received |
7-P | REASONS FOR DEATH WITH A FUNCTIONING KIDNEY GRAFT AND REASONS FOR OVERALL GRAFT FAILURE | Manuel Mayrdorfer | Received |
8-P | PREDICTION MODELS FOR IDEAL GRAFT FUNCTION AFTER LIVING DONOR KIDNEY TRANSPLANTATION ARE USEFUL TO PREDICT GRAFT SURVIVAL | Takahisa Hiramitsu | Received |
9-P | METABOLOMICS APPROACH AND GRAFT FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Dedinská | Received |
9-LBP | EXPERIENCE AND BURDEN OF POST-TRANSPLANT CYTOMEGALOVIRUS INFECTION AND TREATMENT FROM THE PATIENTS PERSPECTIVE | Kimberly Davis | Received |
10-LBP | CAN CT ANGIOGRAPHY REPLACE RENAL SCINTIGRAPHY FOR PREDICTION OF SPLIT RENAL FUNCTION IN PREOPERATIVE LIVING KIDNEY DONOR ASSESSMENT? | David Martin | Received |
11-LBP | OPTIMIZATION OF HLA MATCHING IN KIDNEY ALLOCATIONS, WITH MINIMAL EFFECT ON QUEUE | Sapir Israeli | Received |
11-P | Neonatal Kidney Donation for Kidney Shortage: Is this the time? | Dai Nghiem | Received |
12-P | VERY LOW DOSE ANTI-THYMOCYTE GLOBULINS VERSUS BASILIXIMAB IN NON-IMMUNIZED KIDNEY TRANSPLANT RECIPIENTS | Christophe Masset | Received |
13-P | OPERATING THEATRE NURSESMAIN CONCERNS DURING THE OPERATIVE PROCESS OF ORGAN DONATION- A GROUNDED THEORY | Linda Andersson | Received |
14-LBP | IMPROVED KIDNEY PRESERVATION BY OMNISOL COMPARED TO RED BLOOD CELL BASED PERFUSATE FOR 6 HOUR NORMOTHERMIC MACHINE PERFUSION | Benedict Doorschodt | Received |
14-P | LONG-TERM RESULTS OF AB-INITIO INTRODUCTION OF EVEROLIMUS AFTER LIVER TRANSPLANTATION | Domiziana Pedini | Received |
15-P | RESPONSE TO COVID-19 VACCINATION AND CONTIXAGEVIMAB-CILGAVIMAB PROPHYLAXIS IN PATIENTS UNDERGOING LIVER AND KIDNEY TRANSPLANTATION: PRELIMINARY STUDY | Domiziana Pedini | Received |
15-LBP | SINGLE-CELL RNA-SEQ REVEALS THE HETEROGENEITY OF MICROENVIRONMENT BETWEEN BKPYVN AND TCMR | Gang Huang | Received |
16-LBP | OUTCOMES FOR DECEASED DONOR KIDNEY TRANSPLANT FOLLOWING DONOR CARDIAC ARREST: A NATION-WIDE POPULATION-BASED COHORT STUDY | Dimitra Limnatitou | Received |
16-P | PRE-TRANSPLANT MYCOPHENOLATE MOFETIL MAY BE ASSOCIATED WITH REDUCED INTRAHEPATIC CHOLANGIOPATHY IN ABO-INCOMPATIBLE LIVER TRANSPLANTATION | Jinsoo Rhu | Received |
17-LBP | SURVIVAL BENEFIT OF KIDNEY TRANSPLANTATION IN PATIENTS WITH END-STAGE KIDNEY DISEASE AND PRIOR ACUTE MYOCARDIAL INFARCTION | Jae Won Yang | Received |
17-P | HEPATIC ARTERIAL REVASCULARIZATION IN THE FIRST 72 HOURS FOLLOWING LIVING-DONOR LIVER TRANSPLANTATION: SURGICAL OR ENDOVASCULAR?- A PROPOSED ALGORITHM | Ayman M. Abdelhady Osman | Received |
18-P | USE OF ECULIZUMAB IN A CASE OF HISTOLOGICALLY PROVEN RECURRENCE OF COMPLEMENT FACTOR H - RELATED 5 PROTEIN NEPHROPATHY TO A KIDNEY ALLOGRAFT | Isavella Savva | Received |
19-P | PEDIATRIC ORGAN DONATION: SIXTEEN-YEAR EXPERIENCE OF A PEDIATRIC INTENSIVE CARE UNIT / INTENSIVE CARE UNIT IN A LEVEL 3 HOSPITAL FROM 2006 TO 2021 | Sara Rodrigues | Received |
20-LBP | FIVE-YEAR KIDNEY FUNCTION AND OUTCOMES IN ASIAN KIDNEY TRANSPLANT RECIPIENTS CONVERTING FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS | Jaymini Patel | Received |
21-LBP | NO NUMBER TOO HIGH FOR KIDNEY TRANSPLANT RECIPIENTS - UNVEILING THE IMPACT OF A SIXTH mRNA VACCINE DOSE | Markus Hovd | Received |
21-P | THE IMPACT OF DONOR AGE =50 ON PURE LAPAROSCOPIC DONOR RIGHT HEPATECTOMY | Eui Soo Han | Received |
22-P | ISOLATED GLOMERULITIS IS STRONGLY ASSOCIATED WITH THE ABSENCE OF ANTIBODY-MEDIATED REJECTION BY MOLECULAR DIAGNOSTICS | Thomas Schachtner | Received |
22-LBP | EXPLORING THE MOLECULAR PATHWAYS OF INTRACRANIAL ANEURYSM FORMATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE USING PROTEOMIC ANALYSIS | Jin-Myung Kim | Received |
23-LBP | ISCHEMIA-FREE LIVER IMPLANTATION VERSUS NORMOTHERMIC MACHINE PERFUSION: EVALUATION OF FEASIBILITY AND SECURITY | Zhitao Chen | Received |
23-P | TAB-CEL FOR EBV PTLD AFTER FAILURE OF RITUXIMAB CHEMOTHERAPY FOLLOWING SOLID ORGAN OR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT ALLELE | Farsad Eskandary | Received |
24-P | SUCCESSFUL INTERNATIONAL ADOPTION OF A COMPREHENSIVE, INTEROPERABLE, AND SECURE DIGITAL ORGAN OFFERING MANAGEMENT PLATFORM | Jonathan Baldanza | Received |
25-P | THE QUALITY OF LIFE AND QUALITY OF SLEEP SCORE BETWEEN DIALYSIS AND RENAL TRANSPLANTATION | Sanaz Dehghani | Received |
26-P | PREDICTORS OF NON ADHERENCE TO IMMUNOSUPPRESSION IN RENAL TRANSPLANT PATIENTS AT A UNIVERSITY TEACHING HOSPITAL | Georgios Koufopoulos | Received |
26-LBP | ADVANCED MULTIPLEX FLUORESCENCE MICROSCOPY OF AN EXPERIMENTAL PORCINE LUNG TRANSPLANT MODEL | Nicholas Bechet | Received |
27-P | SUBJECTIVE FRAILTY ASSESSMENT COMPARED TO VALIDATED FRAILTY ASSESSMENT IN DIALYSIS ACCESS/TRANSPLANT SURGERY WORKUP HAS POOR ESTIMATION OF AGREEMENT | Georgios Koufopoulos | Received |
28-P | CHORIOCARCINOMA TRANSMITTED WITH THE TRANSPLANT: CASE STUDY | Sanaz Dehghani | Received |
28-LBP | EFFECTS OF HYPOTHERMIC MACHINE PERFUSION ON THE ENDOTHELIUM IN HUMAN KIDNEYS | Leonie Venema | Received |
29-P | PREDICTORS AND ADVERSE OUTCOMES OF ACUTE KIDNEY INJURY IN HOSPITALIZED RENAL TRANSPLANT RECIPIENTS | Tammy Hod | Received |
30-P | EVALUATION OF THE CLINICAL EXPRESSION OF IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS | Tammy Hod | Received |
30-LBP | HEPATITIS B SURFACE ANTIGEN POSITIVE DONORS FOR LIVER RECIPIENTS WITH HEPATOCELLULAR CARCINOMA: A SINGLE CENTRE EXPERIENCE | Bianca Magro | Received |
31-P | NORMOTHERMIC MACHINE PERFUSION INDUCED REMARKABLE BIOLOGICAL CHANGESOF MARGINAL DONOR KIDNEYS AS DEMONSTRATED BY PROTEOMICS. | Gianluigi Zaza | Received |
31-LBP | ACTIVE PARTICIPATION DURING THE EDUCATIONAL PROCESS OF DONATION AFTER CIRCULATORY DEATH AT EXTRA CORPOREAL MEMBRANE OXYGENATION INTENSIVE CARE UNITS. | Emilie Gripewall | Received |
32-LBP | CHANGES IN ENDOGENOUS PEPTIDES IN DCD KIDNEY BIOPSIES ASSOCIATE WITH PROLONGED WARM ISCHAEMIA | Rebecca Vaughan | Received |
32-P | ESOT-TLJ 3.0 CONSENSUS ON HISTOPATHOLOGICAL ANALYSIS OF PRE-IMPLANTATION DONOR KIDNEY BIOPSY: REDEFINING THE ROLE IN THE PROCESS OF GRAFT ASSESSMENT. | Gianluigi Zaza | Received |
33-P | MULTI-CENTRIC ANALYTICAL PERFORMANCE VALIDATION OF AN IVD ASSAY TO QUANTIFY DONOR-DERIVED CELL-FREE DNA FOR SOLID ORGAN TRANSPLANT SURVEILLANCE | Thierry Viard | Received |
34-LBP | 440 CONSECUTIVE HAND-ASSISTED-RETROPERITONEOSCOPIC-DONOR-NEPHRECTOMIES(HARP). A COMPREHENSIVE ANALYSIS OF THE INTRAOPERATIVE CHALLENGES. | Tristan Wagner | Received |
36-LBP | INCREASED PERCENTAGES OF CD8DR T-CELLS IN PATIENTS WITH DIFFICULT TO CONTROL CMV INFECTION IN SOLID ORGAN RECIPIENTS: A NEW BIOMARKER? | Javier Carbone | Received |
36-P | URINARY RETINOL-BINDING PROTEIN 4 IS ASSOCIATED WITH RENAL FUNCTION AND RAPID RENAL FUNCTION DECLINE IN KIDNEY TRANSPLANT RECIPIENTS | Samuel Lee | Received |
37-P | DEVELOPING A STANDARDIZED EDUCATION PROGRAM ON DECEASED ORGAN AND TISSUE DONATION FOR PRE-MEDICAL AND MEDIAL STUDENTS IN KOREA | Samuel Lee | Received |
38-LBP | JOINT ALLOTRANSPLANTATION: A SYSTEMATIC LITERATURE REVIEW AND EXPERIMENTAL EXAMINATION OF IMMUNE REJECTION OF CARTILAGE | lei zhang | Received |
38-P | TOCILIZUMAB FOR CHRONIC ANTIBODY-MEDIATED REJECTION- 5 YEARS OF EXPERIENCE | Bojana imunov | Received |
39-P | MAGNETIC RESONANCE IMAGING OF RENAL OXYGEN METABOLISM BY MEANS OF 17O ADMINISTRATION DURING EX VIVO ORGAN PERFUSION | Carolina Campos Pamplona | Received |
39-LBP | ACCESS TO AND RESULTS OF TRANSPLANTS IN CATALONIA; REVIEW FROM THE STANDPOINT OF GENDER. | Jaume Tort | Received |
40-P | VOXE: TRANSFORMING CARE IN SOLID ORGAN TRANSPLANT THROUGH THE INTEGRATION OF A DIGITAL PATIENT-REPORTED OUTCOME PLATFORM IN CLINICAL PRACTICE | Samantha Anthony | Received |
40-LBP | GRAFT FAILURE AND DEATH AMONG OLDER PRIMARY DECEASED DONOR KIDNEY RECIPIENTS IN THE UNITED STATES | Samy Riad | Received |
41-P | CREATION OF AN ORGAN TRANSPLANT CAREGIVER EDUCATIONAL RESOURCE & LESSONS LEARNED | Heather Bruschwein | Received |
42-LBP | ISCHEMIA-FREE LIVER TRANSPLANTATION AS A NOVEL APPROACH TO OPTIMIZE TRANSPLANT OUTCOME IN THE ACUTE-ON-CHRONIC LIVER FAILURE SCENARIO | Jun Kang | Received |
43-P | THE OUTCOMES OF ADJUSTED IMMUNOSUPPRESSIVE PROTOCOLS DURING DIFFERENT PHASES OF COVID-19 PANDEMIC IN KIDNEY TRANSPLANT RECIPIENTS | aglar Ruhi | Received |
43-LBP | SUCCESSFUL REPLANTATION OF PORCINE FORELIMBS 33 HOURS AFTER AMPUTATION USING 24-HOUR EX VIVO PERFUSION | lei zhang | Received |
44-LBP | EX VIVO CHARACTERIZATION OF KIDNEY TRANSPLANT TUBULAR EPITHELIAL CELL CO-STIMULATORY AND -INHIBITORY MOLECULE EXPRESSION DURING INFLAMMATION | Constantin Thieme | Received |
45-LBP | SURFACE MOLECULE EXPRESSION OF KIDNEY TUBULAR EPITHELIAL CELL DERIVED EXTRACELLULAR VESICLES A NEW PERSPECTIVE ON THE MODULATION OF ALLOIMMUNITY? | Luka Queitsch | Received |
46-LBP | UNSUPERVISED ANALYSIS OF KIDNEY BIOPSY TRANSCRIPTOMES FROM DONORS AFTER BRAINSTEM OR CARDIAC DEATH | Rachel Thomas | Received |
46-P | PREDICTION OF HERPES VIRUS INFECTIONS AFTER SOLID ORGAN TRANSPLANTATION: A PROSPECTIVE STUDY OF IMMUNE FUNCTION | Dina Leth Mller | Received |
47-P | PREGNANCY OUTCOMES IN FEMALE ABDOMINAL ORGAN TRANSPLANT RECIPIENTS | Lisa Coscia | Received |
48-P | EVEROLIMUS POSSIBLY SUPPRESS ANTI-HLA CLASS II PRODUCTION AFTER LIVING DONOR RENAL TRANSPLANTATION | Shunji Narumi | Received |
49-P | THE DIFFERENCE BETWEEN ECHOCARDIOGRAPHIC FINDINGS BASED ON THE CAUSE OF BRAIN DEATH: A SINGLE-CENTER STUDY IN SINA ORGAN PROCUREMENT UNIT | Azadeh Sadatnaseri | Received |
49-LBP | IMPACT OF PROLONGED NORMOTHERMIC MACHINE PERFUSION ON THE BIOENERGETIC FUNCTION IN PORCINE DBD KIDNEYS | Marlene Pühringer-Sturmayr | Received |
51-LBP | ANEMIA AFTER KIDNEY TRANSPLANTATION - HOW CAN WE MANAGE? | Ivana Dedinská | Received |
51-P | A LOW ABUNDANCE OF HLA IN URINARY EXTRACELLULAR VESICLES HINDERS THE IDENTIFICATION OF DONOR-SPECIFIC VESICLES IN URINE AFTER KIDNEY TRANSPLANTATION | Karin Boer | Received |
52-LBP | THE DETRIMENTAL EFFECTS OF A BK POLYOMAVIRUS INFECTION IN KIDNEY TRANSPLANT PATIENTS | Wouter Moest | Received |
53-P | ANALYSIS OF TREATMENT PREFERENCES, NEEDS, IMMUNOSUPPRESSANT ADHERENCE, AND MENTAL HEALTH DISORDERS IN KIDNEY TRANSPLANT PATIENTS | Carlos Jimenez | Received |
53-LBP | ASSOCIATION OF HEMOGLOBIN LEVELS WITH RENAL FUNCTION DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE KIDNEYS: A RETROSPECTIVE COHORT STUDY | L. Annick van Furth | Received |
54-P | CLINICAL EFFECTS OF VALACYCLOVIR-BASED CYTOMEGALOVIRUS PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS | Jin Sug Kim | Received |
55-P | SELECTION OF SAFE DONORS FOR THE LIVING DONOR LIVER TRANSPLANTATION USING EXTENDED RIGHT LOBE GRAFT | Sung Yeon Hong | Received |
55-LBP | GROUND BREAKING DECISIONAL ROLE OF TRANSIT TIME DURING A LIVING DONOR TRANSPLANTATION EVALUATED BY A FAST AND FRUGAL TREE | Gianluca Rompianesi | Received |
56-P | SYSTEMIC IMMUNE-INFLAMMATORY MARKER OF HIGH MELD PATIENTS IS ASSOCIATED WITH EARLY MORTALITY AFTER LIVER TRANSPLANTATION | Sung Yeon Hong | Received |
56-LBP | 35 YEARS OF PAEDIATRIC HEART TRANSPLANTATION: OUTCOMES AT A VERY LONG TERM FOLLOW-UP | Chiara Tessari | Received |
57-P | MALIGNANCY AFTER KIDNEY TRANSPLANT - 50 YEARS EXPERIENCE | Shunji Narumi | Received |
58-LBP | HEART TRANSPLANTATION (HTX) IN ELDERLY PATIENTS: CROSS-SECTIONAL SINGLE CENTER OBSERVATIONAL STUDY | Agnieszka Kuczaj | Received |
58-P | A LOW SURGICAL APGAR IS A STRONG DETERMINANT OF THE RISK OF DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION | Florent Von Tokarski | Received |
59-P | PRETRANSPLANT HBA1C AS AN EASY TOOL TO IDENTIFY PATIENTS AT HIGH RISK OF DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION | yassine Laghrib | Received |
59-LBP | PROLONGED EX VIVO KIDNEY PRESERVATION USING SUBNORMOTHERMIC ACELLULAR MACHINE PERFUSION | Sara Akalay | Received |
60-P | COMPARING OUTCOMES IN EXTENDED VERSUS STANDARD CRITERIA LIVING DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTRE ANALYSIS | Nikolaos-Andreas Anastasopoulos | Received |
60-LBP | PRELIMINARY RESULTS OF CYTOKINE PROFILING AND ADSORPTION DURING SUBNORMOTHERMIC MACHINE PERFUSION OF ECD LIVER GRAFTS | Sabrina Stimmeder | Received |
61-P | PROSPECTIVE ASSESSMENT OF THE NEED FOR AND ADDED VALUE OF MOLECULAR DIAGNOSTICS OF KIDNEY ALLOGRAFT BIOPSIES AN EVALUATION IN CLINICAL PRACTICE | Thomas Schachtner | Received |
62-P | EFFECTS OF A QUADRUPLE IMMUNOSUPPRESSANT REGIMEN INCLUDING EARLY ADD-ON EVEROLIMUS AFTER KIDNEY TRANSPLANTATION | Hitoshi Iwamoto | Received |
63-LBP | DONATION AFTER CIRCULATORY DEATH INCREASES OVERALL ORGAN DONATION AND TRANSPLANTATION IN SWEDEN, BUT NOT WITHOUT NEW CHALLENGES. | Helena Almén | Received |
63-P | THE IRANIAN EXPERIENCE OF PEDIATRIC ORGAN DONATION | Sanaz Dehghani | Received |
64-P | PATIENTS PERSPECTIVE AND UTILITY OF SELF-NARRATIVE BIOGRAPHIES IN THE KIDNEY TRANSPLANTATION PATH | Marika Morabito | Received |
64-LBP | HEART TRANSPLANTATION FROM ANTI-HBCORE POSITIVE DONORS: A SINGLE-CENTER OBSERVATIONAL STUDY | Agnieszka Kuczaj | Received |
65-LBP | THE IMPACT OF DECEASED DONOR ORGAN PROCUREMENT WORKSHOP ON SURGICAL TRANSPLANT FELLOWS CONFIDENCE AND COMPETENCE | Shilpa Balaji | Received |
65-P | VITALLINKS SCHOOL EDUCATION PROGRAM TO NURTURE THE VALUE OF SHARING AND DECEASED ORGAN DONATION FOR TEENAGERS | Jieun Oh | Received |
66-LBP | DISTINCT CYTOKINE SIGNATURES ACCORDING TO MODEL FOR END-STAGE LIVER DISEASE SCORES AFTER LIVING DONOR LIVER TRANSPLANTATION | Ami Woo | Received |
67-LBP | SURGICAL TREATMENT OF THE PAPILLARY RENAL CELL CARCINOMA IN THE TRANSPLANTED KIDNEY. CASE REPORT | Stefan Hulik | Received |
68-P | TRANSMISIÓN DE VIRUS DE LA HEPATITIS C DE DONANTE VIRÉMICO A RECEPTOR SERONEGATIVO A TRAVÉS DEL INJERTO TEJIDO. UN ESTUDIO PROSPECTIVO | Antonio Franco | Received |
69-LBP | DIGITAL DONOR EVALUATION TOOL: A NEW TECHNOLOGY IMPROVES DONOR ENROLLMENT ON INTENSIVE CARE UNIT | Chiara Selina Imbimbo | Received |
70-LBP | RENAL INSUFFICIENCY CAUSES RAPID GROWTH OF PEDIATRIC KIDNEY GRAFT IN A PEDIATRIC-TO-ADULT KIDNEY TRANSPLANTATION RAT MODEL | Tianhui Pan | Received |
70-P | 17?-ESTRADIOL AND METHYLPREDNISOLONE ASSOCIATED EFFECTS ON RENAL INFLAMMATION INDUCED BY BRAIN DEATH IN FEMALE RATS | Marina Vidal dos Santos | Received |
71-LBP | ATTACHMENT AND PARENTAL BOND: IMPACT ON PSYCHOPATHOLOGY, MENTAL HEALTH AND QUALITY OF LIFE OF KIDNEY TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY | Maria Luisa Pistorio | Received |
71-P | FIRST ROUTINE CLINICAL APPLICATION OF MOLECULAR MICROSCOPE (MMDX) IN EUROPE | Ondrej Viklicky | Received |
72-P | PERFORMANCE OF A NOVEL NGS ASSAY SUITABLE FOR MONITORING DD-CFDNA FOLLOWING KIDNEY TRANSPLANTATION | Sofia Carlén | Received |
73-P | A MULTI-CENTRE STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF EXTENDED-RELEASE TACROLIMUS (LCPT) IN DE NOVO LIVER TRANSPLANT PATIENTS | Thomas Soliman | Received |
74-P | FROM PEN TO CLOUD INTRODUCTION OF A DIGITAL DOCUMENTATION PLATFORM FOR ORGAN DONATION COORDINATORS | Marcus Nauwerk | Received |
79-P | HYPERTENSION AFTER LIVING DONOR KIDNEY DONATION IN THE ERA OF EXTENDED DONOR ELIGIBILITY CRITERIA | Rostand Emmanuel Nguefouet Momo | Received |
80-P | PLASMA CELL-FREE DEOXYRIBONUCLEIC ACID AND SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS | Alison Graver | Received |
81-P | REVISED USUAL INTERSTITIAL PNEUMONIA DIAGNOSES IN EXPLANT LUNGS AFTER THE CURRENT INTERNATIONAL GUIDELINES: A 17-YEAR BICENTRIC EXPERIENCE | Federica Pezzuto | Received |
82-P | CLINICAL OUTCOMES AND QUALITY OF LIFE IN CHILDREN WITH METHYLMALONIC ACIDAEMIA AND END-STAGE KIDNEY DISEASE; A PROMISING FUTURE | Charalampos Kapogiannis | Received |
85-P | FUROSEMIDE ATTENUATES TUBULOINTERSTITIAL INJURY AND ALLOWS FUNCTIONAL TESTING OF PORCINE KIDNEYS DURING NORMOTHERMIC MACHINE PERFUSION | Baran Ogurlu | Received |
86-P | REPROGRAMMING MITOCHONDRIAL METABOLISM TO REDUCE ORGAN TRANSPLANT ISCHEMIA REPERFUSION INJURY | Margaret Huang | Received |
88-P | KINETICS OF POST-TRANSPLANTATION DIABETES MELLITUS IN A LARGE COHORT OF KIDNEY TRANSPLANT PATIENTS | Anne Elisabeth Heng | Received |
89-P | JEJUNAL OR ILEAL EXOCRINE DRAINAGE IN PANCREAS TRANSPLANTATION? GASTROINTESTINAL IMPACT | Jaimee Tan | Received |
90-P | LONG-TERM RESULTS OF HEART TRANSPLANTATION IN RECIPIENTS WITH PRIMARY CARDIAC SARCOMA | Anna Goncharova | Received |
91-P | HEALTH-RELATED QUALITY OF LIFE IN OLDER RECIPIENTS: THE BRIGHT SIGHT OF LIFE FIVE YEARS AFTER KIDNEY TRANSPLANTATION | Vasiliki Tsarpali | Received |
92-P | EFFECT OF BASILIXIMAB INDUCTION IN PEDIATRIC KIDNEY TRANSPLANTATION. A SYSTEMATIC REVIEW AND META-ANALYSIS. | Kavyesh Vivek | Received |
93-P | OPTIMAL TACROLIMUS LEVELS FOR PREVENTING MALIGNANCY AS WELL AS GRAFT FAILURE IN KIDNEY TRANSPLANT PATIENTS | Jaeseok Yang | Received |
94-P | CHALLENGES EXPERIENCED BY ADULT LIVER DONORS AFTER LIVING DONOR LIVER TRANSPLANTATION: AN INTEGRATIVE REVIEW | Seongmi Choi | Received |
95-P | LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: IS THERE A CURATIVE TREATMENT FOR DISSEMINATED RECURRENCE? | Maria Arteaga Ledesma | Received |
96-P | Aspects of Self-Management after Solid Organ Transplantation | Stefan Jobst | Received |
97-P | HYPOTHERMIC OXYGENATED MACHINE PERFUSION IN EXTENDED CRITERIA DONORS, A SPANISH EXPERIENCE | Alberto Pueyo Rabanal | Received |
98-P | ORGAN DONATION IN PATIENTS ON VENOARTERIAL ECMO SUPPORT - SINGLE CENTER EXPERIENCE | Lukas Kielberger | Received |
99-P | CLINICAL PERFORMANCE OF THE IPREDICTLIVING TOOL FOR THE PREDICTION OF POST-TRANSPLANT RECIPIENT AND LIVING DONOR OUTCOMES IN A EUROPEAN COHORT | Jorge Malheiro | Received |
100-P | WALKING IS FUN BUT WALKING TOGETHER IS EVEN MORE FUN: AN EVALUATION OF THE WALK&TALK PROGRAM IN THE NETHERLANDS. | Coby Annema | Received |
101-P | BROADENING CRITERIA FOR DONOR LIVERS: SUCCESSFUL LIVER TRANSPLANTATION OF TWO DONOR LIVERS WITH PORTAL VENOUS GAS | Rama Mikhail | Received |
102-P | IMPACT OF HEMOADSORPTION ON PHARMACOKINETICS OF IMMUNOSUPPRESSIVE DRUGS IN A SHEEP MODEL | Teresa Klaus | Received |
103-P | YOU CAN LEARN FROM EACH OTHER AND GROW: EXPERIENCES OF ADOLESCENT THORACIC TRANSPLANT RECIPIENTS PARTICIPATING IN THE IPEER2PEER MENTORSHIP PROGRAM | Samantha Anthony | Received |
104-P | IMPROVEMENT GAPS TO DEAL WITH THE SHORTAGE OF LUNGS FOR TRANSPLANTATION FROM A MIDDLE INCOME COUNTRYS PERSPECTIVE | Brian Alvarez | Received |
105-P | WEVE ALL GONE THROUGH THE SAME JOURNEY: EFFECTIVENESS OF A MINDFULNESS-BASED RETREAT FOR MOTHERS OF PEDIATRIC HEART TRANSPLANT RECIPIENTS | Samantha Anthony | Received |
107-P | ADIPONECTIN / LEPTIN RATIO AS AN INDEX TO DETERMINE METABOLIC RISK IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Gra&328;ák | Received |
108-P | BLUEPRINTING EXTENDED REALITY AND TANGIBLE RESOURCES FOR SURGICAL EDUCATION; EXPERIENCES AND POTENTIALITIES FROM THE ENTICE PROJECT. | Panagiotis Antoniou | Received |
109-P | ADIPONECTIN / LEPTIN RATIO AS A PREDICTOR OF ACUTE REJECTION IN EARLY POST-TRANSPLANT PERIOD IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Granák | Received |
110-P | ANTICOAGULATION DECREASE THE VENOUS THROMBOSIS IN KIDNEY TRANSPLANTATION FROM UNCONTROLLED DONATION AFTER CARDIAC ARREST WITH HIGH RESISTANCE INDEX | María Molina | Received |
111-P | A PERSISTENT LEFT SUPERIOR VENA CAVA IN A PATIENT WITH RIGHT SUPERIOR VENA CAVA THROMBOSIS UNDERGOING EMERGENCY LT | Hana Kwoun | Received |
112-P | MULTIPLE ARTERY ANASTOMOSIS IN KIDNEY TRANSPLANTATION ; INTERNAL ILIAC ARTERY INTERPOSITION GRAFT | Jongpo Kim | Received |
113-P | USE OF NATIVE URETER IN RE-INTERVENTIONS AFTER KIDNEY TRANSPLANTATION | Edip Akpinar | Received |
114-P | INTRAOPERATIVE SOMATIC TISSUE OXYGEN SATURATION FOR DETECTING POSTOPERATIVE EARLY KIDNEY DYSFUNCTION PATIENTS UNDERGOING LDLT | Seunghee Cha | Received |
115-P | ORGAN DONATION: PROMOTING INTER-CULTURAL AND INTER-FAITH DIALOGUE | David Paredes-Zapata | Received |
117-P | THE USE OF HISTOPATHOLOGICAL FEATURES AS ENDPOINTS IN ACUTE T CELL-MEDIATED REJECTION (TCMR) RESPONSE IN RENAL ALLOGRAFTS | B. Handan Ozdemir | Received |
118-P | RENAL ALLOGRAFT BIOPSY FINDINGS IN PATIENTS WITH COVID-19 | B. Handan Ozdemir | Received |
120-P | PSYCHOSOCIAL ASSESSMENT AMONG DECEASED DONOR KIDNEY TRANSPLANTATION CANDIDATES IN SOUTH KOREA | Hye Jin Chong | Received |
121-P | DONOR, RECIPIENT AND SURGEON SEX AND SEX-CONCORDANCE AND THEIR IMPACT ON LIVER TRANSPLANT OUTCOME | Laura Mazilescu | Received |
123-P | PATIENT EXPERIENCE IN TRANSPLANTATION- A QUALITATIVE ANALYSIS USING FINDINGS OF THE ORGAN UTILISATION GROUP REPORT | Claire Williment | Received |
124-P | OUTCOME OF 40 LIVING DONOR LIVER TRANSPLANTATIONS IN A NEWLY ESTABLISHED ADULT LIVING DONOR LIVER TRANSPLANT PROGRAM IN THE NETHERLANDS | Alicia Chorley | Received |
126-P | POST REPERFUSION SYNDROME IN PEDIATRIC LIVER TRANSPLANTATION: EXPERIENCE OF A CENTER (LYON). | Catherine Boucaud-Le-Brun | Received |
128-P | THIS FAMILY AND THE GAMES ARE MY WORLD: CONCEPTUALISING THE BRITISH AND EUROPEAN TRANSPLANT GAMES AS THERAPEUTIC LANDSCAPES | Abbie Greig | Received |
129-P | EVALUATING OF THE BLOOD PRESSURE PROFILE AFTER KIDNEY TRANSPLANTATION | Seyf Eddine Nassim Sabri | Received |
130-P | FAMILY-CENTRED APPROACH FOR ORGAN DONATION AUTHORISATION: A GROUNDED THEORY STUDY | Lissette Aviles | Received |
131-P | POLYCYSTIC DISEASE: A CUMBERSOME INDICATION FOR TRANSPLANTATION | Alberto Calleri | Received |
132-P | ANALYSIS OF COVID19 CASES WITH RENAL TRANSPLANTATION (KTX): PREDICTIVE FACTIORS OF SEVERE DISEASE | Edip AKPINAR | Received |
133-P | ASSOCIATION BETWEEN TELOMERE LENGTH, MITOCHONDRIA DYSFUNCTION AND KLOTHO LEVELS IN KIDNEY TRANSPLANT RECIPIENTS | Woo Yeong Park | Received |
134-P | INCIDENCE OF MALIGNANCIES AFTER LUNG TRANSPLANTATION AND THEIR EFFECT ON OUTCOME. A 26 YEARS EXPERIENCE. | Konstantina Spetsotaki | Received |
135-P | LIVER TRANSPLANTATION AT THE KOREA UNIVERSITY : ANALYSIS OF 500 CASES AND INTRODUCING OUR UNIQUE MULTI-INSTITUTIONAL NETWORK | Young-Dong Yu | Received |
136-P | COMPARISON STUDY BETWEEN FULL THICKNESS AND ANTERIOR LAMELLAR CORNEAL XENOTRANSPLANTATION FROM SAME TRANGENIC PIGS TO MONKEY | Ik Jin Yun | Received |
137-P | CONTRAST ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY IN THE EARLY PERIOD AFTER RENAL TRANSPLANTATION | Ji-Il Kim | Received |
139-P | PASSENGER LYMPHOCYTE SYNDROME PRESENTED AS HEMOLYTIC ANEMIA AFTER SMALL BOWEL TRANSPLANTATION: A CASE REPORT | Jeongkye Hwang | Received |
141-P | PREDICTIVE MODEL OF TRANSPLANTED KIDNEY FUNCTION USING AUTOMATED COMPUTED TOMOGRAPHY VOLUMETRY | Dha Woon Im | Received |
142-P | LAPAROSCOPIC HAND-ASSISTED DONOR HEMINEPHRECTOMY IN LIVING DONOR WITH HORSESHOE KIDNEY (CASE PRESENTATION) | Islam Madadov | Received |
145-P | HEMOSTATIC PROTEIN PRODUCTION DURING LONG-TERM EX SITU NORMOTHERMIC MACHINE PERFUSION OF HUMAN DONOR LIVERS RESULTS IN PLASMA-LIKE PERFUSION FLUID | Bianca Lascaris | Received |
146-P | NO QUICK-FIX IN DETECTING SARCOPENIA IN PATIENTS ENLISTED FOR KIDNEY TRANSPLANTATION - MEASUREMENTS OF PSOAS MUSCLE | Hkon Heldal | Received |
147-P | UTILIZATION AND CLINICAL OUTCOMES OF SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION FROM OLDER PANCREAS DONORS. | Jeevan Gopal | Received |
149-P | IMPACT OF COVID-19 SAFETY MEASURES ON NON-COVID-19 INFECTIONS IN SOLID ORGAN TRANSPLANT PATIENTS DURING THE PANDEMIC; A SINGLE CENTRE STUDY. | Aeliya Zaidi | Received |
150-P | THE QUALITY OF LIFE OF LIVING LIVER DONORS POST-DONATION: AN AMBIDIRECTIONAL COHORT STUDY | Hayo ter Burg | Received |
151-P | SUCCESSFUL KIDNEY TRANSPLANTATION WITH ARTERIAL RECONSTRUCTION FROM A DECEASED DONOR WITH MARFANS SYNDROME A CASE REPORT. | Agnieszka Mizerska | Received |
152-P | PERIOPERATIVE TRANEXAMIC ACID IN RENAL TRANSPLANTATION WILL IT BLEED OR WILL IT CLOT? | Nader Bedwani | Received |
153-P | DIVERSITY OF CIRCULATING B CELL SUBSETS INRENAL TRANSPLANT RECIPIENTS EARLY POSTTRANSPLANT. | Ariadni Fouza | Received |
154-P | ATHEROSCLEROSIS AND INTRARENAL RESISTANCE INDEX IN KIDNEY TRANSPLANT RECIPIENTS | Tim Swaab | Received |
155-P | COVID-19 EFFECT ON KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE COHORT STUDY | Eleni Avramidou | Received |
158-P | THE EVACADE STUDY: DD-CFDNA FOR DIAGNOSIS OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION ON BEHALF OF THE SPANISH WORKING GROUP ON TRANSPLANT IMMUNOLOGY | Francisco Boix | Received |
159-P | NEUTROPHIL-TO-LYMPHOCYTE RATIO AND FRAILTY: HIGHLY PREDICTIVE TOOLS FOR CYTOMEGALOVIRUS INFECTIONS IN KIDNEY TRANSPLANT PATIENTS | Bing Jie Chow | Received |
160-P | THE IBOX SCORE AS A PREDICTIVE FACTOR IN A RETROSPECTIVE KIDNEY RETRANSPLANT COHORT | Valeria Wagner | Received |
161-P | EARLY GRAFT FUNCTION USING PREDICTED DONOR RENAL CORTICAL VOLUME WITH CT IMAGE ANALYSIS | Taiki Ogasa | Received |
162-P | SERIOUS ADVERSE REACTIONS AND SERIOUS ADVERSE EVENTS ANALYSIS IN ORGAN DONATION AND TRANSPLANTATION NETWORK FROM 2012 TO 2021 | Federica Domini | Received |
163-P | SCOPING REVIEW OF CURRENT DEVELOPMENTS OF RADIONOMICS IN KIDNEY TRANSPLANTATION | Jie Yen | Received |
164-P | FAILURE TO RESCUE RATE TO BETTER ANALYZE SURGICAL COMPLICATIONS AFTER 500 PEDIATRIC LIVING DONOR LIVER TRANSPLANTATIONS. | Aniss Channaoui | Received |
165-P | DONATION AFTER CARDIOCIRCULATORY DEATH IN PATIENTS OLDER THAN 70 YEARS | Ramón Mula Martínez | Received |
166-P | NAĎVE T CELL-DEPLETED HEMATOPOIETIC GRAFT COMBINED WITH SOLID ORGAN TRANSPLANTATION AS STRATEGY TO INDUCE TOLERANCE | Carlos Jimenez | Received |
167-P | MANAGEMENT OF BKV INFECTION AND NEPHROPATHY IN KIDNEY TRANPLANT RECIPIENTS; NINE YEARS OF EXPERIENCE | aglar Ruhi | Received |
169-P | ASSESSMENT OF DD-CFDNA IN KIDNEY TRANSPLANTATION AS A MARKER OF GRAFT INJURY A PROSPECTIVE STUDY | José Silvano | Received |
170-P | EX VIVO NORMOTHERMIC CIRCULATION (PNEV) OF GRAFTS FROM DCDS. AN EXPERIMENTAL STUDY OF BIOCHEMICAL AND METABOLIC CONDITION | Marina Mata | Received |
171-P | SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT IPSILATERAL VERSUS CONTRALATERAL, A SINGLE UNIT EXPERIENCE | Lorenzo Petagna | Received |
172-P | EARLY DETERMINATION OF FAST TACROLIMUS METABOLIZER STATUS IDENTIFY RISK OF REJECTION AND ALLOGRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS | Christophe Masset | Received |
173-P | EVOLUTION OF HUMORAL RESPONSE TO SARS-COV-2 VACCINATION AFTER KIDNEY TRANSPLANTATION IN PATIENTS PREVIOUSLY VACCINATED WHILE ON THE WAITING LIST | Christophe Masset | Received |
174-P | ASSOCIATION BETWEEN HLA MOLECULAR MISMATCH AND HISTOLOGICAL REJECTION IN KIDNEY ALLOGRAFT | Sook Park | Received |
175-P | METABOLIC ACIDOSIS INCREASES MORTALITY AND PROGRESSION OF CHRONIC GRAFT FAILURE IN PATIENTS LONG TERM AFTER KIDNEY TRANSPLANTATION | Marcin Adamczak | Received |
176-P | LIVER GRAFT REDUCTION THROUGH EX-VIVO RIGHT POSTERIOR SECTIONECTOMY: SINGLE CENTER EXPERIENCE IN PREVENTING LARGE-FOR-SIZE SYNDROME | Andrea Della Penn | Received |
177-P | EFFECT OF RECONSTRUCTION TYPE OF DUAL ARTERIES ON LONG-TERM OUTCOME IN LIVING DONOR KIDNEY TRANSPLANTATION | Won-Bae Chang | Received |
180-P | THE PREVALENCE OF DYSLIPIDEMIA BEFORE AND AFTER SUCCESSFUL LIVER TRANSPLANTATION | Marcin Adamczak | Received |
181-P | IMPACT OF HUANGS CLASSIFICATION ON MANAGEMENT OF BILIARY STRICTURES IN LIVING DONOR LIVER TRANSPLANTATION | Shahzad Riyaz | Received |
183-P | CLINICAL OUTCOME OF LUNG TRANSPLANTATION IN CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE | Hyeyoung Hong | Received |
184-P | 48HR NORMOTHERMIC MACHINE PERFUSION WITH URINE RECIRCULATION FOR DISCARDED HUMAN KIDNEY GRAFTS: A CASE SERIES | Franka Messner | Received |
185-P | THE QUESTIONABLE BURDEN OF AB0 INCOMPATIBLE KIDNEY TRANSPLANTATION | Caroline Berchtold | Received |
187-P | PLASMA FGF21 CONCENTRATION IN KIDNEY TRANSPLANT RECIPIENTS | Marcin Adamczak | Received |
189-P | INCREASED TACROLIMUS TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS WITH COVID-19 | Faiza Sebhi | Received |
190-P | THE OUTCOMES OF FISTULA TRACT EMBOLIZATION FOR ANASTOMOTIC BILIARY LEAKAGE AFTER LIVING DONOR LIVER TRANSPLANTATION | Hae Won Lee | Received |
191-P | DONORS AGE MODIFIES THE IMPACT OF PRE-DONATION ESTIMATED GLOMERULAR FILTRATION RATE ON CENSORED GRAFT SURVIVAL | Jorge Malheiro | Received |
192-P | URINARY LEVELS OF V-SET IG DOMAIN-CONTAINING 4 (VSIG4) ARE ASSOCIATED WITH CHRONIC CHANGES IN TRANSPLANT KIDNEYS | Sang Youb Han | Received |
196-P | FUNCTIONAL OUTCOMES AFTER ALEMTUZUMAB THERAPY FOR T-CELL MEDIATED, ANTIBODY-MEDIATED AND MIXED KIDNEY TRANSPLANT REJECTION | Lukas van Vugt | Received |
197-P | SYSTEMATIC REPORTING AND INVESTIGATION OF POSSIBLE INFECTION OF DONOR ORIGIN IN DECEASED ORGAN DONATION IS ESSENTIAL FOR BEST TRANSPLANTATION PRACTICE | Ines Ushiro-Lumb | Received |
198-P | EARLY RESULTS OF A SCREENING PROGRAM FOR SKIN CANCER IN LIVER TRANSPLANT RECIPIENTS: A COHORT STUDY | Dina Leth Mller | Received |
200-P | FACTORS THAT INFLUENCE THE DEVELOPMENT AND IMPLEMENTATION OF PREHABILITATION FOR KIDNEY TRANSPLANT CANDIDATES: A MIXED-METHODS CONTEXTUAL ANALYSIS | Avril Haanstra | Received |
203-P | PRE-TRANSPLANT PROPORTIONS OF POLYFUNCTIONAL DONOR-REACTIVE T CELLS ARE ASSOCIATED WITH ACUTE T-CELL MEDIATED REJECTION OF THE KIDNEY TRANSPLANT | Nicolle Litjens | Received |
205-P | VIGILANCE DATA IN ORGAN DONATION AND SOLID ORGAN TRANSPLANTATION IN GERMANY: DONOR-DERIVED DISEASE TRANSMISSION FROM 2016-2022. | Ana Paula Barreiros | Received |
206-P | MULTIPARAMETER ANALYSIS OF ALLOREACTIVE T CELLS IDENTIFIED BY ACTIVATION-INDUCED MARKERS (AIMS); DIFFERENT AIMS RECOGNIZE SPECIFIC T CELL SUBSETS | Nicolle Litjens | Received |
207-P | REMAINING STEROID FREE ONE YEAR AFTER KIDNEY TRANSPLANTATION | Lada Zibar | Received |
208-P | MICROSURGICAL ANASTOMOSIS BETWEEN LOWER POLAR ARTERY AND INFERIOR EPIGASTRIC ARTERY IN KIDNEY TRANSPLANT: SINGLE CENTRE EXPERIENCE | Matteo Zanchetta | Received |
209-P | INTRAOPERATIVE MEASURES OF VASCULAR FLOW IN LIVER TRANSPLANT. WHAT CAN THEY REALLY FORESEE? | María Arteaga Ledesma | Received |
210-P | PATIENTS EXPERIENCES OF PATHWAY CARE AFTER KIDNEY TRANSPLANTATION: FINDINGS FROM AN ITALIAN ETHNOGRAPHIC RESEARCH | Enrica Baraldi | Received |
211-P | MESENCHYMAL STEM CELLS INFUSION DURING LIVER RESECTION AND TRANSPLANTATION REGENERATION AUGMENTATION AND IMMUNE MODULATION: CASE REPORT | Denis Efimov | Received |
212-P | LONG-TERM PRESERVATION OF KIDNEYS BY MEANS OF CRYOPERFUSION: THE NEXT STEP IN ORGAN PRESERVATION? | Carolina Campos Pamplona | Received |
213-P | AWARENESS CAMPAIGN FOR ORGAN DONATION THROUGH SOCIAL MEDIA AND PODCASTS: AN INNOVATIVE APPROACH | Enrica Baraldi | Received |
214-P | HORMONAL PROFILE OF FEMALES INFLUENCES INTESTINAL REPERCUSSIONS IN POTENTIAL BRAIN-DEAD DONORS | Fernanda Yamamoto Ricardo da Silva | Received |
216-P | DONOR-DERIVED CELL-FREE DNA AND GENE EXPRESSION PROFILE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Maria Jose Ramirez-Bajo | Received |
217-P | SARCOPENIA BUT NOT FRAILTY IS ASSOCIATED WITH A SPECIFIC METABOLOMIC SIGNATURE IN KIDNEY TRANSPLANT CANDIDATES | Maria Jose Perez Saez | Received |
218-P | EFFICACY OF DESENSITIZATION IN HLA-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION | Marta Blanco Pardo | Received |
220-P | NEOPLASTIC COMPLICATIONS IN PATIENTS WITH LONG-TERM RENAL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE | Marco Busutti | Received |
221-P | EVALUATING THE USE OF CONTINUOUS GLUCOSE MONITORING (CGM) EARLY AFTER KIDNEY TRANSPLANTATION | Georgios Eleftheriadis | Received |
222-P | CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION IMPROVES RENAL FUNCTION: A SINGLE CENTER EXPERIENCE | Daniela Kniepeiss | Received |
224-P | PROGNOSTIC VALUE OF CREATININE REDUCTION RATIO AT POSTOPERATIVE DAY 2 AFTER KIDNEY TRANSPLANTATION | Florent Von Tokarski | Received |
225-P | OPTIMIZING PATIENT THRIVING DURING THE TRANSPLANT PROCESS | Camilla Nonterah | Received |
226-P | IS IMPLANTABLE DOPPLER PROBE USEFUL AS A VASCULAR MONITORING DEVICE IN KIDNEY TRANSPLANT PATIENTS: A RETROSPECTIVE COHORT, SINGLE CENTRE STUDY. | Shahzar Malik | Received |
227-P | PPI CONSULTATION ON THE PROTOCOL DEVELOPMENT OF A STUDY INVESTIGATING THE FEASIBILITY OF THE IMPLANTABLE DOPPLER PROBE IN KIDNEY TRANSPLANTATION | Shahzar Malik | Received |
228-P | COMPARISON OF COVID-19 AFTER KIDNEY TRANSPLANTATION BEFORE AND AFTER THE OMICRON VARIANT EPIDEMIC IN JAPAN | Kenta Futamura | Received |
229-P | URINE-DERIVED STEM CELL ATTENUATED RENAL FIBROSIS AFTER ISCHEMIA REPERFUSION VIA KLOTHO ACTIVATION | Jae Wan Jeon | Received |
230-P | DELETION OF PTP4A1 AMELIORATE RENAL FIBROSIS INDUCED BY UUO IN MICE. | Yunkyeong Hwang | Received |
231-P | THE LONG-TERM RISKS OF KIDNEY DONATION (RENAL RESERVE, HYPERTENSION): OBSERVATIONS FROM A 15-YEAR FOLLOW-UP PERIOD AT THE MILITARY MEDICAL ACADEMY | Jelena Tadic | Received |
232-P | PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS IN A BELGIAN COHORT OF LUNG TRANSPLANT CANDIDATES: THE PROGRESS STUDY | Edwin Curraj | Received |
233-P | REDUCTION OF ORGAN ALLOCATION TIMES | Federica Domini | Received |
234-P | FUTURE-PROOFING DECEASED DONOR KIDNEY TRANSPLANTATION: FIRST RESULTS OF A UNIQUE COLLABORATIVE BETWEEN FIVE TRANSPLANT CENTRES IN A METROPOLITAN AREA | Isaac Kim | Received |
235-P | EXTENDING THE USE OF WEB PORTAL FOEDUS TO UNITED KINGDOM ORGANIZATION (NHS) AND EUROTRANSPLANT IN 2022 | Federica Domini | Received |
236-P | ASSOCIATION BETWEEN ADULT DBD KIDNEY OFFER DECLINE RATES AND RISK-ADJUSTED WAITING TIMES IN THE UNITED KINGDOM | Lisa Mumford | Received |
238-P | THE EFFICACY OF FERROPTOSIS INHIBITION IN KIDNEY ISCHEMIA REPERFUSION INJURY AND TRANSPLANTATION: A SYSTEMATIC REVIEW | Lene Devos | Received |
239-P | REAL LIFE SINGLE-CENTRE EXPERIENCE IN PATIENTS WITH LONG-SURVIVAL RENAL TRANSPLANTATION | Marco Busutti | Received |
240-P | CARDIOVASCULAR EVENTS AFTER KIDNEY TRANSPLANTATION AND LONG-TERM OUTCOMES. | Elizabete Junk | Received |
241-P | MISMATCHED HUMAN LEUCOCYTE ANTIGENS BETWEEN BLOOD DONORS AND WAITLISTED TRANSPLANT PATIENTS LEADS TO TRANSFUSION SPECIFIC HLA-B ANTIBODIES | Katrina Spensley | Received |
242-P | PROGESTERONE EFFECTS ON INTESTINAL CHANGES CAUSED BY ISCHEMIA AND REPERFUSION PROCESS | Brunella Valbăo | Received |
243-P | KIDNEY QUALITY ASSESSMENT USING LASER SPECKLE CONTRAST IMAGING DURING NORMOTHERMIC MACHINE PERFUSION | Yitian Fang | Received |
245-P | THE EXPERIENCES OF HEALTH CARE PROFESSIONALS APPROACHING FAMILIES FOR ORGAN DONATION CONSENT: A MIXED-METHOD SYSTEMATIC REVIEW | Liset Pengel | Received |
246-P | NORMOTHERMIC MACHINE PERFUSION ALTERS RENAL GENE EXPRESSION PATTERNS | Veerle A. Lantinga | Received |
247-P | DEFINING THE STABILIZATION POINT OF KIDNEY FUNCTION FOLLOWING TRANSPLANTATION: AN OBSERVATIONAL COHORT STUDY | Evert Cleenders | Received |
248-P | Characterization of SARS-COV-2 spike-specific CD4 T-cells after mRNA-1273 vaccination in kidney and lung transplantation recipients | Céline Imhof | Received |
251-P | POST-LIVER TRANSPLANTATION RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS: ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | Luisa Pasulo | Received |
252-P | EXPLORING THE TRENDS IN SYSTEMATIC REVIEWS OF KIDNEY TRANSPLANTATION: A COMPREHENSIVE ANALYSIS OF THE EVIDENCE BASE OVER A DECADE | Sarah Salih | Received |
253-P | HUMORAL AND CELLULAR RESPONSE AFTER THE 3RD TOZINAMERAN DOSE IS ACCOMPANIED WITH ACTIVATION OF CERTAIN LYMPHOCYTE SUBPOPULATIONS | Asimina FYLAKTOU | Received |
254-P | HEMOCHROMATOSIS IN KIDNEY TRANSPLANT RECIPIENTS: CASE SERIES | SEDA SAFAK OZTURK | Received |
255-P | PORCINE PRECISION-CUT LIVER SLICES AS AN ACCOMPANYING MODEL TO STUDY PERFUSATE COMPOSITION DURING LONG-TERM LIVER NORMOTHERMIC PERFUSION | Julia Hofmann | Received |
256-P | ATYPICAL HAEMOLYTIC UREMIC SYNDROME (AHUS) RECURRENCE AFTER KIDNEY TRANSPLANTATION IN PATIENTS WITH ECULIZUMAB PROPHYLAXIS | Marta Blanco Pardo | Received |
257-P | HUMAN LIVER TRANSPLANTATION: EVALUATION OF IMMUNE T CELLS WITH TISSUE REPAIR FUNCTIONS | Bost Romain | Received |
258-P | TAILORED IMMUNOSUPPRESSION WITH LCP EXTENDED RELEASE TACROLIMUS BASED ON NFAT-REGULATED GENE EXPRESSION | Judith Kahn | Received |
260-P | TRACER METABOLOMICS DURING NORMOTHERMIC KIDNEY PERFUSION AS A NON-INVASIVE TOOL TO UNRAVEL WHOLE ORGAN KIDNEY METABOLISM | Julie De Beule | Received |
261-P | ISCHEMIA-INDUCED METABOLIC PATTERNS PREDICT KIDNEY FUNCTION DURING PIG NORMOTHERMIC PERFUSION | Julie De Beule | Received |
263-P | SAFETY AND BENEFIT OF A SMALL INCISION FOR DONOR HEPATECTOMY IN LIVING-DONOR LIVER TRANSPLANTATION | Hikaru Hayashi | Received |
265-P | INVESTIGATION OF STUDIES ON PHYSICAL ACTIVITY IN KIDNEY TRANSPLANT RECIPIENTS | Eda Ayten Kankaya | Received |
266-P | FIRST CLINICAL EXPERIENCE WITH TIXAGEVIMAB AND CILGAVIMAB IN LUNG TRANSPLANT RECIPIENTS DURING OMICRON WAVE | Peter Jaksch | Received |
268-P | HISTOLOGICAL SCREENING FOR BK POLYOMAVIRUS NEPHROPATHY FOLLOWING VIRAL REPLICATION IN PLASMA: AN OBSERVATIONAL COHORT STUDY | Evert Cleenders | Received |
269-P | PERI-OPERATIVE KINETICS OF PLASMA MITOCHONDRIAL DNA LEVELS DURING LIVING DONOR KIDNEY TRANSPLANTATION | Nora Spraakman | Received |
270-P | COVID-19 INFECTION IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS AFTER IMMUNIZATION WITH THE BNT162B2 COVID-19 MRNA VACCINE | Varvara Askiti | Received |
272-P | VALGANCICLOVIR VS LETERMOVIR PROPHYLAXIS AND RISK OF CYTOMEGALOVIRUS DNAEMIA IN A RANDOMIZED PHASE 3 TRIAL | Klemens Budde | Received |
273-P | A NEW KIDNEY OFFERING SCHEME IN THE UK - 3 YEAR REVIEW | Lisa Mumford | Received |
274-P | LONGITUDINAL DYNAMICS OF SARS-COV-2 SPIKE-SPECIFIC ANTIBODY RESPONSES IN PATIENTS ON WAITING LIST AND AFTER LUNG TRANSPLANTATION | Evgeny Chichelnitskiy | Received |
275-P | PATIENTS REFERRED TO RETRANSPLANTATION MAY BENEFIT FROM MAINTAINING CALCINEURIN INHIBITOR AFTER KIDNEY TRANSPLANT FAILURE | Kia Hakkarainen | Received |
277-P | THE PROSPECTIVE EFFECT OF LIVING AND DECEASED RELATED DONOR TRANSPLANTATIONS IN PATIENTS IMMUNE PROFILE | Asimina FYLAKTOU | Received |
278-P | LONG TERM SURVIVAL OF THE HEPATOCELLULAR CARCINOMA WITH OR WITHOUT LIVER TRANSPLANTATION | Emre KARAKAYA | Received |
279-P | TARGETED DELETION OF HYPOXIA INDUCIBLE TRANSCRIPTION FACTOR-1? GENE IN CD4 T CELLS IMPROVES VASCULARIZED COMPOSITE ALLOTRANSPLANTATION OUTCOME | Madonna Rica Anggelia | Received |
280-P | EFFECTS OF COLONIZATION WITH MULTIDRUG-RESISTANT BACTERIA ON PNEUMONIA ETIOLOGY IN THE FIRST YEAR AFTER KIDNEY AND HEART TRANSPLANTATION | Zrinka Bosnjak | Received |
281-P | DELAYED REGULATORY T CELL THERAPY FOLLOWING ALEMTUZUMAB INDUCTION | Conor Hennessy | Received |
282-P | A DEEP DIVE ON REAL-WORLD IMMUNOSUPRESSIVE THERAPY PATTERNS FOR RENAL TRANSPLANT PATIENTS IN FRANCE: 10 YEAR FOLLOW-UP DATA FROM THE OISTER STUDY | Dany Anglicheau | Received |
283-P | TOWARDS CREATING A FRAMEWORK FOR ENVIRONMENTAL SUSTAINABILITY IN KIDNEY TRANSPLANTATION SERVICES | Nikolaos-Andreas Anastasopoulos | Received |
284-P | FACTORS ASSOCIATED WITH GROWTH IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE, SINGLE-CENTER COHORT STUDY | VARVARA ASKITi | Received |
285-P | SHORT-TERM PREDICTIVE MODELS FOR POST-KIDNEY TRANSPLANT DIABETES MELLITUS USING MACHINE LEARNING APPROACH: PRELIMINARY DATA | Giae Yun | Received |
286-P | SILICONE DEPOSITIONS, AN UNUSUAL FINDING IN THE EXPLANTED AND NEWLY TRANSPLANTED LUNGS | Saskia Bos | Received |
287-P | CHARACTERISATION OF GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS | Conor Hennessy | Received |
290-P | ALPHA-1 ANTITRYPSIN DEFICIENCY IS UNDERDIAGNOSED IN CIRRHOTIC LIVER TRANSPLANT PATIENTS : A RETROSPECTIVE MULTICENTER STUDY | Audrey Coilly | Received |
291-P | STATE OF KNOWLEDGE OF ALPHA 1 ANTI-TRYPSIN DEFICIENCY AMONG PRACTITIONERS SPECIALIZED IN LIVER TRANSPLANTATION IN FRANCE : A NATIONAL SURVEY | Audrey Coilly | Received |
292-P | THE ROLE OFADIPOCYTOKINES IN DEVELOPMENT OF NEW ONSET DIABETES AFTER LIVER TRANSPLANTATION | Iva Kouta | Received |
293-P | ASSOCIATION BETWEEN PRETRANSPLANT DIALYSIS MODALITY AND LONG-TERM GRAFT OUTCOMES | Taehee Kim | Received |
294-P | CORRELATION OF DD-CFDNA AND REJECTION PHENOTYPES IN A BRAZILIAN PATIENT POPULATION | Helio Tedesco Silva Junior | Received |
296-P | THE IMPACT OF POSTREPERFUSION SYNDROME ON RECIPIENT MORTALITY AND GRAFT FAILURE IN LIVING DONOR LIVER TRANSPLANTATION | Seungwon Lee | Received |
298-P | EFFICACY AND SAFETY OF ECULIZUMAB FOR TREATMENT OF ANTIBODY-MEDIATED REJECTION FOLLOWING RENAL TRANSPLANTATION | Ho Sik Shin | Received |
299-P | CHARACTERIZING ADHERENCE PROFILES BASED ON C0 MONITORING IN KIDNEY TRANSPLANT PATIENTS: ILLUSION OR REALITY? | Caroline Monchaud | Received |
300-P | EVALUATION OF POST REPERFUSION BASELINE BIOPSIES FOR KIDNEY TRANSPLANT OUTCOME | Juan Carlos Torrez | Received |
301-P | A LENGTHENED EUTHANASIA ELIMINATES THE BURDEN OF ORGAN DONATION RELATED PREMORTEM INQUIRIES AND IN HOSPITAL PERFORMED EUTHANASIA. | Hans Sonneveld | Received |
302-P | PREGNANCY OUTCOMES AFTER LIVER AND KIDNEY TRANSPLANTATION | Emre KARAKAYA | Received |
303-P | UROLOGIC COMPLICATIONS AFTER KIDNEY TRANSPLANTATIONS AND THEIR MANAGEMENT | Emre KARAKAYA | Received |
304-P | Post COVID-19 condition is related to antibody levels after COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant | Reshwan Malahe | Received |
305-P | EFFECT OF A NATIONWIDE INTERVENTION TO REDUCE HEPATECTOMY TIMES IN DUTCH ORGAN PROCUREMENT TEAMS | Hanne Verberght | Received |
306-P | THE COST-EFFECTIVENESS OF PROPHYLAXIS IN CYTOMEGALOVIRUS SEROPOSITIVE (CMV R) KIDNEY TRANSPLANT RECIPIENTS OVER THE FIRST YEAR POST-TRANSPLANTATION | Villeneuve Claire | Received |
307-P | RENAL TRANSPLANTATION IN HYPERSENSITIZED PATIENTS. DESENSITIZATION VS. PATHI | Sara Doménica Erráez Guerrero | Received |
308-P | KIDNEY TRANSPLANTATION IN JEHOVAHS WITNESSES: ETHICAL IMPLICATIONS, MANAGEMENT PROPOSAL AND REVIEW OF LITERATURE | Marika Morabito | Received |
310-P | COMPARISON OF PERFUSATE COMPOSITION DURING NORMOTHERMIC LIVER PERFUSION - TRANSPLANTED VERSUS NON-TRANSPLANTED LIVERS | Jule Dingfelder | Received |
311-P | CLINICAL OUTCOMES OF DISTINCT INDUCTION THERAPIES IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANTS FROM CONTROLLED DONORS AFTER CIRCULATORY DEATH (CDCD) | Zaira Ivette Castańeda Amado | Received |
312-P | GPBAR-1/CAMP/PKA SIGNALLING MITIGATES THE MACROPHAGE-MEDIATED ACUTE CHOLESTATIC LIVER INJURY VIA ANTAGONIZING NLRP3-ASC INFLAMMASOME | Yunjie Lu | Received |
313-P | T LYMPHOCYTE SUBSETS IN LONG-TERM KIDNEY TRANSPLANT SURVIVORS | Efstratios Kasimatis | Received |
314-P | SHORT-TERM EFFECTS OF LOSARTAN TREATMENT IN ELDERLY PATIENTS AFTER KIDNEY TRANSPLANTATION AN INTERIM ANALYSIS OF CELART STUDY | Alicja Debska-Slizien | Received |
316-P | QUESTIONNAIRE FOR EXPLORING QUALITY OF LIFE FOLLOWING LIVER TRANSPLANTATION IN ROMANIAN PATIENTS | Speranta Iacob | Received |
320-P | Delayed graft function after kidney transplantation: The role of residual diuresis, oxalic acid, glyoxylic acid, and glycolic acid. | Gideon Post Hospers | Received |
321-P | Pregnancy after Kidney TransplantationImpact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity ofImmunosuppression on Kidney Function and Maternal Health | Mira Choi | Received |
322-P | COMPARISON BETWEEN INTERNAL ILIAC ARTERY AND EXTERNAL ILIAC ARTERY FOR RENAL ARTERY ANASTOMOSIS IN KIDNEY TRANSPLANTATION | Won-Bae Chang | Received |
323-P | SHORT-TERM HEPATITIS B IMMUNOGLOBULIN (HBIG) COMBINED WITH ENTECAVIR IN PREVENTING HBV RECURRENCE IN LIVER TRANSPLANTATION | Hao Zheng | Received |
324-P | ASSESSMENT OF COGNITIVE IMPAIRMENT IN KIDNEY TRANSPLANTATION AND ITS RELATED RISK FACTORS | Hristos Karakizlis | Received |
326-P | BELATACEPT IN RENAL TRANSPLANTATION: A REAL-WORLD PHARMACOKINETIC STUDY | Stephanie CHHUN | Received |
329-P | X-RAY ANALYSIS OF DONOR LUNGS IN EX-VIVO LUNG PERFUSION SYSTEM (EVLP). A PILOT STUDY WITH ASSESSMENT OF THE BRIXIA SCORE TO PREDICT TRANSPLANTABILITY. | Konstantina Spetsotaki | Received |
330-P | CAUSES FOR DISCARDING THE LIVING KIDNEY DONOR CANDIDATE: REVIEW OF THE LAST 20 YEARS AND 837 CANDIDATES | Mňnica Pérez Mir Pérez Mir | Received |
332-P | RISK MANAGEMENT AND SAFETY OF THE PEDIATRIC TRASPLANT PATIENT: THE ROLE OF THE NURSE IN THE PREPARATION OF THE CAREGIVER | Virginia Bove | Received |
334-P | DIALYSIS VINTAGE MATTERS: THE PROFOUND IMPACT OF DIALYSIS VINTAGE ON TRANSPLANT OUTCOMES. | Jan Lindeman | Received |
335-P | TREATMENT OF COMPLEX UROLITHIASIS IN ORTHOTOPIC KIDNEY TRANSPLANT BY ENDOSCOPIC COMBINED INTRARRENAL SURGERY (ECIRS) | Marina Mata | Received |
337-P | THE RISK FACTOR FOR DELAYED GRAFT FUNCTION IN THE DECEASED DONOR KIDNEY TRANSPLANTATION | Ju Ik Moon | Received |
339-P | ISCHEMIA-FREE KIDNEY TRANSPLANTATION: A PILOT STUDY | Guodong Chen | Received |
340-P | HLA INCOMPATIBILITY AND PANEL REACTIVE ANTIBODIES PRIOR TO RENAL TRANSPLANTATION CAN ADVERSELY AFFECT RENAL FUNCTION OUTCOME AND IMMUNE PROFILE | Asimina Fylaktou | Received |
341-P | EDTCO CONGRESS. ORGAN DONOR COORDINATORS LEADERSHIP IN ORGAN DONATION AND TRANSPLANTATION PRACTICE AND POLICY | Lissette Aviles | Received |
343-P | N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL AS A PREDICTOR OF ADVERSE RENAL AND CARDIOVASCULAR OUTCOMES IN STABLE RENAL TRANSPLANT RECIPIENTS. | Klemens Budde | Received |
345-P | MINIMALLY INVASIVE INGUINAL APPROACH IN KIDNEY TRANSPLANT SURGERY BRINGS EXCELLENT OUTCOMES | Rostand Emmanuel Nguefouet Momo | Received |
346-P | A NOVEL APPROACH USING BACTERIOPHAGE FOR MULTI-DRUG RESISTANT BURKHOLDERIA GLADIOLI IN A POST-LUNG TRANSPLANT PATIENT | Graham Hantman | Received |
347-P | A FEASIBILITY STUDY EXPLORING THE IMPACT OF A LOW ADVANCED GLYCATION END-PRODUCT DIET ON SKIN AUTOFLUORESCENCE IN KIDNEY TRANSPLANT RECIPIENTS. | Catherine Johnson | Received |
348-P | MANAGING THE DEFECT IN THE RIGHT RENAL VEIN IN DECEASED DONOR ORGAN PROCUREMENT: A SINGLE CENTRE EXPERIENCE. | Rostand Emmanuel Nguefouet Momo | Received |
349-P | EXTENDED RELEASE TACROLIMUS IN SIMULTANEUS KIDNEY PANCREAS TRANSPLANTATION (SKPT). PRELIMINARY RESULTS OF A PROSPECTIVE STUDY. | Giuseppe Iaria | Received |
350-P | EVALUATION OF DONORS QUALITY OF LIFE AFTER KIDNEY DONATION: SINGLE CENTER EXPERIENCE | Maria Smyrli | Received |
351-P | Haemodynamics in the external iliac artery: The utility of phase-contrast magnetic resonance angiography for investigating transplant renal artery stenosis | Paul Martin | Received |
352-P | IMPACT OF PEG35-BASED SOLUTION ON STEATOTIC LIVER COLD PRESERVATION: INSIGHTS INTO MITOCHONDRIAL PROTECTION AND CELL SIGNALING | Arnau Panisello Rosello | Received |
353-P | VAR-T CELLS: AN INNOVATIVE CELLULAR PLATFORM TO OPTIMIZE THE RESPONSE OF TRANSPLANTED PATIENTS ON THERAPEUTIC IMMUNOSUPPRESSION TO VACCINATION | Rim Hussein-Agha | Received |
355-P | POST-TRANSPLANT THROMBOTIC MICROANGIOPATHY (PT-TMA) AFTER ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION: TWO CASES WITH LOW ISOAGGLUTININ TITLES. | Jorge Malheiro | Received |
356-P | PERFUSATE FROM NORMOTHERMIC MACHINE PERFUSED DISCARDED HUMAN DONOR KIDNEYS HAS AN ANTI-INFLAMMATORY EFFECT ON MONOCYTE-DERIVED DENDRITIC CELLS | Laura Knijff | Received |
357-P | DESENSITIZATION WITH IMLIFIDASE IN CROSSMATCH-POSITIVE, HIGHLY SENSITIZED KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-CENTER EXPERIENCE | Stathis Tsiakas | Received |
358-P | LUMINAL INTESTINAL PRESERVATION FOLLOWING BRAIN DEATH MAY REDUCE INNATE IMMUNE SYSTEM ACTIVATION. | Marc Gjern Weiss | Received |
359-P | ANASTOMOTIC BILIARY LEAKAGE AFTER HEPATICOJEJUNOSTOMY IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION INCIDENCE, MANAGEMENT AND OUTCOME. | Mateusz Ciopi&324;ski | Received |
360-P | REDUCED CARDIOVASCULAR DISEASE ASSESSMENT FOR KIDNEY TRANSPLANT RECIPIENTS- A RETROSPECTIVE COHORT STUDY. | Michael Corr | Received |
361-P | INCIDENCE OF ANTIBODIES AGAINST HUMAN NEUTROPHIL ANTIGENS-3A IN KIDNEY TRANSPLANT CANDIDATES | Angeliki Vittoraki | Received |
362-P | THE IMPACT OF APPLYING UCSF CRITERIA TO PATIENTS UNDERWENT LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN A LOW VOLUME CENTER | Yeon Ho Park | Received |
363-P | A NOMOGRAM FOR PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER KIDNEY TRANSPLANTATION | Guodong Chen | Received |
364-P | THE OUTCOMES OF BK VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS; SINGLE CENTRE EXPERIENCE | Ahmed Saleh | Received |
365-P | THE METHOD OF USING ROBOTIC HARMONIC ULTRASONIC SHEAR FOR PARENCHYMAL TRANSECTION IN ROBOTIC DONOR RIGHT HEPATECTOMY | KWAN WOO KIM | Received |
367-P | COMPARISON IN ANALGESIC EFFICACY BETWEEN NEFOPAM AND ACETAMINOPHEN IN LIVING KIDNEY DONOR | Jaehee Seo | Received |
370-P | IMMUNOSUPRESSIVE TREATMENT AND CD4/CD8 T-CELL EXHAUSTION IMPACT SARS-COV-2-SPECIFIC ADAPTIVE RESPONSES AFTER VACCINATION IN SOLID ORGAN TRANSPLANT | Laura Donadeu | Received |
371-P | A CASE OF ISOLATED KIDNEY TRANSPLANTATION IN A PATIENT WITH PRIMARY HYPEROXALURIA TYPE 1 RECEIVING LUMASIRAN THERAPY | Maria Ilaria Moretti | Received |
372-P | CIRCULATING IRISIN LEVELS IN KIDNEY TRANSPLANT PATIENTS. | Alicja D&281;bska-&346;lizei&324; | Received |
377-P | DISPARITIES IN ORGAN DONATION RATES INSIDE THE EUROPEAN REGION | Brian Alvarez | Received |
378-P | MANAGEMENT OF INCISIONAL HERNIA FOLLOWING ABDOMINAL ORGAN TRANSPLANTATION | Vassilios Papalois | Received |
379-P | TRANSPLANTATION OF UNCONTROLLED DCD KIDNEYS AFTER RECONDITIONING BY A NOVEL EX-VIVO PERFUSION METHOD - REVIVEME TRIAL | Deepti Antony | Received |
380-P | PRO-INFLAMMATORY PROFILE OF ADIPOKINES IN KIDNEY TRANSPLANT RECIPIENTS | Alicja Debska-Slizien | Received |
381-P | PROTOCOL BIOPSY IN LIVING KIDNEY DONOR TRANSPLANTATION. | Khadidja Habchi | Received |
382-P | SHOULD INFECTION IN DECEASED ORGAN DONORS INHIBIT THE DECISION FOR KIDNEY TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE | Dionysios Prevezanos | Received |
385-P | COMPARISON OF PROGNOSIS AND RISK FACTORS OF GRAFT FAILURE BETWEEN PEDIATRIC AND ADULT RECIPIENTS WHO RECEIVED PEDIATRIC DONOR KIDNEY TRANSPLANTATION | Guodong Chen | Received |
386-P | DEVELOPMENT OF RENAL ALLOGRAFT LYMPHANGIECTASIA AFTER 14 YEARS FROM KIDNEY TRANSPLANTATION | Hae Won Park | Received |
387-P | LONG-TERM OUTCOME OF PEDIATRIC LIVER TRANSPLANTS: THE IMMUNOSUPPRESION AND PSYCHO-SOCIAL DEVELOPMENT | Rey-Heng Hu | Received |
390-P | PREVALENCE OF EARLY ACHIEVEMENT OF THERAPEUTIC LEVEL OF MYCOPHENOLATE AFTER A LOADING PROTOCOL AMONG THAI KIDNEY TRANSPLANT RECIPIENTS | Nuttasith Larpparisuth | Received |
391-P | PREGNANCY AFTER LUNG TRANSPLANTATION IN THE NETHERLANDS | Jildau Meinderts | Received |
393-P | EARLY COMPLICATIONS AFTER DESENSITIZED LIVING DONOR KIDNEY TRANSPLANTATION: ANALYSIS OF KOREAN ORGAN TRANSPLANTATION REGISTRY (KOTRY) DATA | Myeonghyeon Ko | Received |
394-P | KOMPARTE. REGISTERING MORE AND BETTER THE DONATION PROCESS | Alberto Sandiumenge | Received |
395-P | ROBOT ASSISTED RETROPERITONEOSCOPIC DONOR NEPHRECTOMY | Emin Baris Akin | Received |
396-P | A NATIONAL SURVEY OF CURRENT PERIOPERATIVE PRACTICES IN LIVER TRANSPLANTATION. Are we ready for enhanced recovery? | Carrie Scuffell | Received |
397-P | EPIDEMIOLOGY OF CANCER AFTER SOLID ORGAN TRANSPLANTATION (EPCOT): AN ENGLISH POPULATION-COHORT PROJECT OF LINKED NATIONAL DATASETS | Charlotte Stephens | Received |
398-P | Hyperreduced Left Lateral Living Donor Liver Transplant in a 4.5 kg Child - A First in Africa | Francisca van der Schyff | Received |
399-P | BLUE KIDNEY, A CHALLENGING CASE FOR LIVING DONOR KIDNEY TRANSPLANTATION | Ala Elcircevi | Received |
400-P | TISSUE DONATION ACTIVITY OF A THIRD LEVEL HOSPITAL ACCORDING TO THE NEW DEFINITIONS ESTABLISHED BY THE CRITICAL PATHWAY | Alberto Sandiumenge | Received |
401-P | ORGAN DONATION AFTER CIRCULATORY DEATH SHALL WE? PERCEPTIONS AND CHALLENGES OF GREEK NURSING PROFESSIONALS - A FOCUS GROUP STUDY | Christina Papachristou | Received |
402-P | CC GENOTYPE OF GNAS C.393CT (RS7121) POLYMORPHISM HAS A PROTECTIVE EFFECT AGAINST DEVELOPMENT OF BK VIREMIA AND BKV-ASSOCIATED NEPHROPATHY | Justa Friebus-Kardash | Received |
403-P | GNB3 C.825CT (RS5443) POLYMORPHISM AND RISK OF ACUTE CARDIOVASCULAR EVENTS AFTER RENAL ALLOGRAFT TRANSPLANT | Justa Friebus-Kardash | Received |
404-P | KIDNEY TRANSPLANT RECIPIENTS IN WHOM CONCENTRATION-CONTROLLED DOSE ADJUSTMENT OF MMF WAS PERFORMED HAD HIGHER REJECTION-FREE SURVIVAL AT THREE YEARS | Alexandre Garnier | Received |
405-P | THE SF12 IS SHORTER AND AS EFFICIENT AS SF36 TO EVALUATE HEATH QUALITY OF LIFE IN KIDNEY TRANSPLANT PATIENTS. | Villeneuve Claire | Received |
406-P | Association of Viral Infection, HLA-Immunization and long-term Graft Survival | Milena Tempel | Received |
407-P | EVALUATION OF THE BENEFIT OF PHARMACEUTICAL INTERVIEWS (PI) FOR DE NOVO KIDNEY TRANSPLANT PATIENTS AT 6 MONTHS. | Malissa Boucida | Received |
409-P | GLOBAL BURDEN OF IMMUNOSUPPRESSION AND ITS ASSOCIATION WITH BKV MORBIDITY IN ABOI VS. PRE-TRANSPLANT DSA-POSITIVE KIDNEY TRANSPLANT RECIPIENTS | Michael Eder | Received |
411-P | PROTEINURIA AND TYPE OF ALLOGRAFT INJURY IDENTIFY KIDNEY TRANSPLANT RECIPIENTS BENEFITING MOST FROM BELATACEPT CONVERSION | Thomas Schachxtner | Received |
412-P | VITALISE-PILOT, A FEASIBILITY PROJECT: EX VIVO OPTIMISATION OF DONOR LUNGS WITH INHALED SEVOFLURANE DURING NORMOTHERMIC EX VIVO LUNG PERFUSION | Shuqi Yang | Received |
413-P | SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION AND ITS EFFECT ON BONE | Simona Kratochvílová | Received |
415-P | NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH INDICATION AND FOLLOW-UP GRAFT BIOPSIES AT ONE AND THREE YEARS | Eulŕlia Solŕ Porta | Received |
416-P | RESTING LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION CAUSING CRITICAL ILLNESS, TO TRANSPLANT OR NOT TO TRANSPLANT? | Roy Baskin | Received |
417-P | FACTORS ASSOCIATED WITH PREMATURE LOSS OF KIDNEY GRAFTS FROM OLDER DONORS | Betty Chamoun Huacón | Received |
418-P | FACTORS ASSOCIATED WITH HEALTH RELATED QUALITY OF LIFE IN A GREEK COHORT OF KIDNEY TRANSPLANT RECIPIENTS: A PROSPECTIVE STUDY | Vasileios Koutlas | Received |
420-P | FROM PALLIATION TO FULL-TIME OCCUPATION: CYSTIC FIBROSIS PATIENT WITH BURKHOLDERIA CEPACIA COMPLEX ON ECMO SURVIVES LUNG TRANSPLANT AND BASAL MENINGITIS | Macé Schuurmans | Received |
421-P | Effect of Maternal Living Donor Liver Grafts in Rates of Rejection and Graft Loss | Francisca van der Schyff | Received |
422-P | REMARKABLE MORTALITY BEFORE LIVER TRANSPLANT IN BILIARY ATRESIA; PRELIMINARY OUTCOMES FROM A 14-YEAR COHORT STUDY | Amirali Mashhadiagha | Received |
423-P | THE INFLUENCE OF ANTIBODIES AGAINST MICA ON THE OUTCOME OF KIDNEY TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY | Ioannis Bellos | Received |
425-P | INFECTION, VACCINATION OR BOTH? THE SARS-COV-2 IMMUNE FOLLOW-UP OF KIDNEY AND LIVER TRANSPLANT RECIPIENTS. | Krzysztof Mucha | Received |
426-P | TRANSCRIPTIONAL PROFILES IN BLOOD AND URINE FROM KIDNEY TRANSPLANT PATIENTS WITH REJECTION AND GRAFT ACCEPTANCE | Cristian Alvarez | Received |
427-P | THE INFLUENCE OF ANTIBODIES AGAINST ANGIOTENSIN II TYPE-1 RECEPTOR ON THE OUTCOME OF KIDNEY TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY | Kalliopi Vallianou | Received |
429-P | Recovery from severe heart failure after lumasiran, pyridoxine, and isolated kidney transplantation in primary hyperoxaluria type 1 | Mira Choi | Received |
430-P | THE MINIMIZATION OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: A 3-YEAR PATIENT FOLLOW UP. | Emilia Kniola | Received |
431-P | CROSS-PLATFORM VALIDATION OF MOLECULAR MARKERS FOR REJECTION PHENOTYPES AFTER KIDNEY TRANSPLANTATION | Jasper Callemeyn | Received |
432-P | DE NOVO FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN THE KIDNEY ALLOGRAFT: ONE LESION, DIFFERENT OUTCOMES | Marion RABANT | Received |
433-P | DONOR-DERIVED CELL-FREE DNA IDENTIFIES TROUBLED KIDNEY ALLOGRAFTS. | Emilio Rodrigo | Received |
434-P | AGILE DATA JOURNEY AND GOVERNANCE TO LEVERAGE DIGITAL TRANSFORMATION OF A KIDNEY TRANSPLANT CENTER IN COLOMBIA | Andrea Garci Lopez | Received |
435-P | EDUCATION ON DIGITAL TRANSFORMATION: A PRIORITY TO MAXIMIZE ITS BENEFITS AND USES. EXPERIENCE OF A SINGLE CENTER IN LATIN AMERICA. | Andrea Garcia Lopez | Received |
436-P | TECHNICAL FAILURE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: INCIDENCE AND PREDICTORS FROM THE LARGEST PORTUGUESE CENTER OVER 20-YEARS | Bruno José Fraga Dias | Received |
437-P | SAFETY PROFILE OF SGLT2 INHIBITORS IN RENAL TRANSPLANT PATIENTS | caroline dudreuilh | Received |
439-P | NURSING EXPERIENCE WITH TELEMEDICINE DURING THE COVID-19 PANDEMIC IN THE CARE OF PATIENTS AFTER LIVER TRANSPLANTATION | Ilka Boin | Received |
440-P | PREDICTING INDEX FOR OUTCOMES AFTER DECEASED DONOR LIVER TRANSPLANT | Jiyoung Baik | Received |
442-P | DISCREPANCY BETWEEN PULMONARY ARTERY CATHETER AND CO-OXIMETRY VALUE OF MIXED VENOUS OXYGEN SATURATION DURING LIVER TRANSPLANTATION | Gaabsoo Kim | Received |
445-P | THE EFFECT OF STEROID PULSE THERAPY FOR THE REDUCTION OF ACUTE REJECTION EPISODE IN SUBCLINICAL BORDERLINE CHANGES : AN OPEN-LABEL, RANDOMIZED TRIAL | Hyunjung Ryu | Received |
447-P | IMMUNOLOGIC RESPONSE TO SARS-COV-2 VACCINATION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Nikoleta Printza | Received |
448-P | IMPACT OF NONSPECIFIC ALLOGRAFT BIOPSY FINDINGS IN SYMPTOMATIC KIDNEY TRANSPLANT RECIPIENTS | Bon Jin Koo | Received |
449-P | DELAYED GRAFT FUNCTION EFFECT ON T CELL SUBPOPULATIONS FOLLOWING RENAL TRANSPLANTATION | Efstratios Kasimatis | Received |
450-P | HAPLOIDENTICAL HSCT WITH KIR GENOTYPE MISMATCHED: DIMINISHED RISK OF MORTALITY, DISEASE-FREE MORTALITY AND ACUTE GVHD | Marlon Castrillon Álvarez | Received |
451-P | CIRCULATING IMMUNE CELL SUBSETS CORRELATE WITH INDICES OF LEFT VENTRICULAR FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS WITHOUT CARDIOVASCULAR DISEASE. | EVANGELIA DOUNOUSI | Received |
452-P | EVALUATION OF A READY-TO-USE AND FULLY AUTOMATED REAL-TIME PCR TO DETECT 11 VIRUSES IN HUMAN SAMPLES | Maria Avelia De Lorenzis | Received |
453-P | IMMUNE CELL REPERTOIRE IN KIDNEY TRANSPLANT BIOPSIES CLASSIFIED AS ACUTE REJECTION | Marian Clahsen-van Groningen | Received |
454-P | DEVELOPMENT OF A PARATHYROID CELL THERAPY ADAPTED FOR ALLO- AND XENO- TRANSPLANTATION FOR THE TREATMENT OF HYPOPARATHYROIDISM. | Mehdi Maanaoui | Received |
455-P | PRELIMINARY RESULTS OF INTRAOPERATIVE VASCULAR FLOW ASSESSMENT IN KIDNEY TRANSPLANTATION | Gianluca Rompianesi | Received |
456-P | FRACTION OF EXHALED NITRIC OXIDE IN LIVER TRANSPLANT RECIPIENTS AND MATCHED CONTROLS | Nicoline Stender Arentoft | Received |
457-P | Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study | Maaike Schagen | Received |
458-P | PERSON-CENTERED APPROACH IN DESIGNING A LEAN LIVING DONOR KIDNEY TRANSPLANT PATH: ADD VALUE OF IMPROVEMENT TOOLS | Rubba Fabiana | Received |
460-P | THE PROGNOSTIC VALUE OF LYMPHOCYTE SUBSETS IN ANTIBODY RESPONSE AFTER SARS-COV2 VACCINATION IN DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS. | Ioannis Mallioras | Received |
461-P | NATURAL KILLER CELLS BEFORE KIDNEY TRANSPLANTATION INVOLVED WITH OPPORTUNISTIC INFECTION. | Marie Matignon | Received |
462-P | PREVALENCE OF PERIPHERAL ARTERY DISEASE IN LIVER TRANSPLANT RECIPIENTS | Nicoline Stender Arentoft | Received |
465-P | AMBULATORY BLOOD PRESSURE MONITORING PRIOR TO KIDNEY DONATION | Lilia Ben Fatma | Received |
468-P | LUNG FUNCTION AFTER THORACO-ABDOMINAL NORMOTHERMIC REGIONAL PERFUSION IN A PORCINE DCD MODEL | Michiel Hu | Received |
474-P | HISTOLOGICAL ANALYSIS OF EXPRESSION OF AT1R, ETAR AND ADHESION MOLECULES IN PEDIATRIC KIDNEY TRANSPLANT PROTOCOL BIOPSIES | Elisa Benetti | Received |
475-P | SUCCESSFUL DESENSITIZATION WITH IMLIFIDASE AND DARATUMUAB IN A HIGHLY IMMUNIZED, CROSSMATCH POSITIVE LIVING-DONOR RE-TRANSPLANT RECIPIENT | Fabian Halleck | Received |
476-P | IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND PREVENTION OF SUDDEN CARDIAC DEATH IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Juric | Received |
478-P | HLA-DQ MISMATCHING AND RENAL TRANSPLANT OUTCOMES IN THE UK | Hatem Ali | Received |
479-P | HIGHEST RESPONSE RATES OF VECTOR CONTAINING REGIMENS AFTER FOUR DOSES OF COVID-19 VACCINES IN RENAL TRANSPLANT RECIPIENTS | Tina Schmidt | Received |
480-P | DIAGNOSTIC POTENTIAL OF SEQUENCING BASED T CELL ANALYSIS IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE | Nina Babel | Received |
481-P | ENDOVASCULAR TREATMENT OF RESISTANT RENOVASCULAR HYPERTENSION IN A PATIENT WITH MIDDLE AORTIC SYNDROME (CLINICAL CASE) | Stepan Sakhovskiy | Received |
482-P | LONGITUDINAL ANALYSIS OF PERIPHERAL BLOOD IMMUNE CELL SUBSETS IN KIDNEY TRANSPLANT RECIPIENTS AND CLINICAL CORRELATIONS A PROSPECTIVE STUDY. | EVANGELIA DOUNOUSI | Received |
483-P | RESULTS OF NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH PROVIDED BY A MOBILE ECMO TEAM ACROSS THE REGION OF MADRID | Nuria Martinez Sanz | Received |
484-P | IMPACT OF CONVERSION OF TWICE-DAILY TACROLIMUS TO ONCE-DAILY EXTENDED-RELEASE MELTDOSE TACROLIMUS ON CELLULAR IMMUNITY | Nina Babel | Received |
485-P | PERFORMANCE OF DIFFERENT ESTIMATED GLOMERULAR FILTRATION RATE EQUATIONS IN PREDICTING END-STAGE KIDNEY DISEASE EARLY AFTER LIVER TRANSPLANTATION | Tuija Innanen | Received |
486-P | NOVEL ANTIBODIES TO TARGET THE MEMBRANE ATTACK COMPLEX IN TREATING KIDNEY ISCHAEMIA REPERFUSION INJURY | Aeliya Zaidi | Received |
488-P | STRONGEST IMMUNOGENICITY OF HETEROLOGOUS COVID-19 VECTOR/MRNA VACCINATION IN COMPARISON TO HOMOLOGOUS REGIMENS IN KIDNEY AND LUNG RECIPIENTS | Tina Schmidt | Received |
489-P | IMPACT OF IMMUNOSSUPRESSION WITHDRAWAL IN DONOR(HLA)-SPECIFIC MEMORY B CELL RESPONSES IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS | Alba Torija Recasens | Received |
491-P | THE CLINICAL RELEVANCE OF BONE MARROW BIOPSY IN SOLID ORGAN TRANSPLANT RECIPIENTS. | Krzysztof Mucha | Received |
493-P | HIGH INCIDENCE AND VIRAL LOAD OF HHV-6A IN A MULTI-CENTRE KIDNEY TRANSPLANT COHORT | Nina Babel | Received |
494-P | Nutrient supplementation during Normothermic Machine Perfusion may be beneficial for support of the mitochondrial metabolism | Dafni Efraimoglou | Received |
495-P | TRANSEUROPEAN EDUCATIONAL INITIATIVE IN ORGAN DONATION AND TRANSPLANTATION | Chloe Balleste | Received |
496-P | OPPOSITE EFFECTS IN FRACTIONAL DONOR-DERIVED CELL-FREE DNA FROM URINE AND PLASMA IN KIDNEY RECIPIENTS? RESULTS FROM A PILOT STUDY. | Fanny Sandberg | Received |
497-P | URINARY BIOMARKERS IN A LIVING DONOR KIDNEY TRANSPLANTATION COHORT PREDICTIVE VALUE ON EARLY AND LONG-TERM GRAFT FUNCTION. | Nora Spraakman | Received |
499-P | MULTIMODAL REMOTE HOME-MONITORING OF LUNG TRANSPLANT RECIPIENTS DURING COVID-19 VACCINATIONS: PILOT STUDY OF THE COVIDA DESK | Macé Schuurmans | Received |
500-P | COVID-19: ROLE OF RESILIENCE ON THE PSYCHOLOGICAL IMPACT OF LOCKDOWN IN LIVER TRANSPLANT TRANSITIONAL CANDIDATES AND RECIPIENTS | Luisa Pasulo | Received |
501-P | RISK AND PROGNOSTIC FACTORS FOR POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS A POLISH MULTICENTER STUDY. | Krzysztof Mucha | Received |
502-P | LUNG PRESERVATION AT 4C TO 8C WITH A NOVEL LUNG STORAGE DEVICE: FIRST EUROPEAN EXPERIENCE | An-Lies Provoost | Received |
503-P | PUSHING THE BOUNDARIES OF DELISTING UNACCEPTABLE HLA IN HIGHLY SENSITISED PATIENTS IN CONTEXT OF NOVEL DESENSITISATION - USING C1Q ASSAY | Riddhi Singh | Received |
505-P | EFFECT OF (MICRO)THROMBI IN DONOR LUNGS ON LUNG FUNCTION DURING EX VIVO LUNG PERFUSION AND POST-OPERATIVE OUTCOMES | Michiel Hu | Received |
506-P | DONOR QUALITY OF LIFE AND PSYCHOSOCIAL OUTCOMES AFTER LIVING DONOR KIDNEY TRANSPLANTATION | Vassilios Papalois | Received |
507-P | MEASUREMENT OF THE IMMUNOSUPPRESSANT POSSESSION RATIO BY CLINICAL PHARMACISTS CAPTURES A NON-ADHERENCE ASSOCIATED WITH ANTIBODY-MEDIATED REJECTION | Jérémy Chambord | Received |
508-P | KNOWLEDGE EXCHANGE PROGRAM TO FACILITATE THE CREATION OF ORGAN DONATION UNITS IN SAUDI ARABIA | Brian Alvarez | Received |
509-P | POST-TRANSPLANT DIABETES MELLITUS IN KIDNEY TRANSPLANT PATIENTS ONE CENTRE PILOT, PROSPECTIVE STUDY. | Alicja Debska-Slizien | Received |
510-P | PREVALENCE AND RISK FACTORS FOR ARTERIAL HYPERTENSION IN LIVER TRANSPLANT RECIPIENTS | Nicoline Stender Arentoft | Received |
511-P | KIDNEY TRANSPLANT IN HIGHLY SENSITIZED PATIENT: IMLIFIDASE DESENSITIZATION, C1Q-BINDING DELISTING AND TIMELY TREATMENT OF ANTIBODY-MEDIATED REJECTION | Lucrezia Furian | Received |
515-P | THE EFFECT OF STEM CELL-DERIVED EXTRACELLULAR VESICLES ON ISCHEMIA REPERFUSION INJURY IN SOLID ORGAN TRANSPLANTATION: A SYSTEMATIC REVIEW | Nicholas Gilbo | Received |
517-P | EXTRACELLULAR MATRIX - KEY COMPONENT IN THE PRODUCTION OF FUNCTIONAL AND PHYSIOLOGICALLY STABLE ARTIFICIAL PANCREATIC ISLETS USING THE INKJET METHOD | Michal Wszola | Received |
518-P | HEALTHCARE WORKERS AND ADMINISTRATIVE STAFF PERCEPTION OF ORGAN DONATION IN TWO HOSPITALS | Andrea Garcia Lopez | Received |
519-P | THE MANY FACES OF HUMAN HERPES VIRUS 8 (HHV 8) DISEASE: CASE REPORT OF A PAEDIATRIC LIVER TRANSPLANT RECIPIENT | Marisa Beretta | Received |
520-P | COMPARATIVE ANALYSIS OF INCOMPATIBLE ABO VS INCOMPATIBLE HLA LIVING DONOR KIDNEY TRANSPLANTATION | Sara Domenica Erraez Guerrero | Received |
521-P | GENE EXPRESSION ANALYSIS AND HISTOLOGICAL DIAGNOSIS OF TRANSPLANT BIOPSIES TAKEN AT THE TIME OF DONOR-SPECIFIC ANTIBODY DETECTION. | Jack Beadle | Received |
522-P | SOCIAL SUPPORT AND EDUCATION REINFORCEMENT MODIFIABLE FACTORS FOR NON-COMPLIANCE IN RENAL TRANSPLANT RECIPIENTS. RESULTS OF A CROSS-SECTIONAL STUDY. | Andrea Garcia Lopez | Received |
523-P | A POLICY OF VERY SHORT PRESERVATION TIME IMPROVES THE RESULTS OF SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION FROM EXTENDED CRITERIA DONORS | Renaud Snanoudj | Received |
525-P | THROMBOTIC MICROANGIOPATHY AFTER ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: ASSESSMENT OF ANTI-A ANTIBODIES BY LUMINEX SINGLE ANTIGEN ASSAY. | Dominique Bertrand | Received |
526-P | EARLY CMV REACTIVATION IN RENAL RECIPIENTS IS ASSOCIATED WITH PRE-TRANSPLANT HIGH EXPRESSION OF BCMA TRANSCRIPTS, PLASMABLAST & CLASS-SWITCHED B CELL | Manuel Muro | Received |
527-P | CURRENT INSIGHTS INTO THE METABOLOME DURING HYPOTHERMIC KIDNEY PERFUSION. | Laurence Verstraeten | Received |
529-P | PERCEPTIONS, EMOTIONS AND SOCIAL REPRESENTATIONS RELATED TO ORGAN DONATION IN HEALTHCARE WORKERS: A QUALITATIVE RESEARCH STUDY AFTER THE COVID-19 | Margherita Gentile | Received |
530-P | CLINICAL UTILITY OF GENETIC TESTING IN A KIDNEY TRANSPLANT CLINIC | Aina Quilis | Received |
531-P | VALIDITY OF CT DEFINED BODY COMPOSITION AS A PROGNOSTIC FACTOR FOR LONG TERM FUNCTIONAL OUTCOME IN KIDNEY TRANSPLANTATION RECIPIENTS. | Tim Swaab | Received |
532-P | YOUR DEATH, MY LIFE - A FOCUS GROUP STUDY REGARDING THE ATTITUDES OF THE GREEK POPULATION TOWARDS ORGAN DONATION AFTER CIRCULATORY DEATH | Christina Papachristou | Received |
534-P | RACE-FREE VERSUS RACE-DEPENDENT ESTIMATED GLOMERULAR FILTRATION RATE AMONG KIDNEY-TRANSPLANTED PATIENTS ONE YEAR AFTER TRANSPLANTATION | Ingrid Charlotte Kongerud | Received |
535-P | RECIPIENT WARM ISCHEMIA TIME AND ITS IMPACT ON GRAFT FUNCTION AND HISTOLOGY AT 3 MONTHS | Yosu Luque | Received |
536-P | IMMEDIATE VERSUS DELAYED ABDOMINAL WALL CLOSURE AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION USING A GORE-TEX PATCH: A SINGLE CENTER EXPERIENCE | Valeria Wagner | Received |
537-P | ASYMPTOMATIC GRAFT INFECTION | Pooja Budhiraja | Received |
538-P | LETERMOVIR AS A RESCUE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH VALGANCICLOVIR/GANCICLOVIR REFRACTORY/RESISTANT CMV DISEASE | Linde Gao | Received |
539-P | ORTHOTOPIC ROBOT-ASSISTED KIDNEY TRANSPLANTATION: A NOVEL TECHNIQUE AND CASE SERIES | Begońa Etcheverry Giadrosich | Received |
540-P | PROGNOSTIC VALUE OF A POSITIVE CROSSMATCH BEFORE DESENSITIZATION IN A COHORT OF HIGHLY-SENSITIZED PATIENTS | Johan Noble | Received |
542-P | EDUCATIONAL INTERVENTION AS AN APPROACH TO SUPPORT COUNTRIES IN EUROPEAN REGION TOWARDS ACHIEVING SELF-SUFFICIENCY IN TRANSPLANTATION | Chloe Balleste | Received |
544-P | VISIONEM AN AI PLATFORM FOR ORGAN ASSESSMENT | Concepción Gómez-Gavara | Received |
545-P | ENHANCED VIABILITY AND FUNCTION DURING PROLONGED CARDIAC GRAFT PRESERVATION USING THE VP.S ENCORE OXYGENATED MACHINE PERFUSION DEVICE | Kristina Andrijauskaite | Received |
546-P | SEARCHING NEW DONATION SCENARIOS: POTENCIAL RECEPTORS ON THE OTHER SIDE OF THE MIRROR | Ramón Mula Martínez | Received |
547-P | PERSISTENT HYPERPARATHYROIDISM AFTER PREEMPTIVE KIDNEY TRANSPLANTATION | Manabu Okada | Received |
548-P | A RANDOMISED CONTROLLED TRIAL TO COMPARE STANDARD AND TORQUE TENO VIRUS GUIDED IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION - TTVGUIDEIT PROTOCOL | Frederik Haupenthal | Received |
549-P | Mycophenolate mofetil severely hampers protective antibody responses to a broad range of vaccinations in kidney transplant recipients: results from a randomized controlled study. | Zainab Al Fatly | Received |
550-P | INCREASING ACCESS TO LIVING DONOR TRANSPLANTS BY OVERCOMING BARRIERS TO RECIPIENTS IDENTIFYING A LIVING DONOR | Bruce Gelb | Received |
551-P | PRE-TREATMENT OF DONOR TISSUE IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: A SYSTEMATIC REVIEW | David Tran | Received |
552-P | ASSOCIATION BETWEEN INTRAOPERATIVE FLUID MANAGEMENT AND POSTOPERATIVE OUTCOMES IN LIVING KIDNEY DONORS | Chisong Chung | Received |
553-P | RNA-SEQUENCING REVEALS A CONSERVED MECHANISM OF ACUTE REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION ACROSS PATIENTS AND ANATOMICAL LOCATION | David Tran | Received |
554-P | STREAMLINING DONATION TRANSPLANTATION COMMUNICATION VIA HIPAA-COMPLIANT APP | John Piano | Received |
555-P | STREAMLINING TRANSPLANTATION VIA A COMPREHENSIVE AND SECURE DIGITAL TRANSPLANT MANAGEMENT PLATFORM | John Piano | Received |
557-P | TECHNICAL FEASIBILITY OF WHOLE-EYE VASCULAR COMPOSITE ALLOTRANSPLANTATION: A SYSTEMATIC REVIEW | David Tran | Received |
558-P | SAFETY AND UTILITY OF ADJUVANT AND CONCOMITANT PANNICULECTOMY IN RENAL TRANSPLANT CANDIDATES | David Tran | Received |
559-P | THE ROLE OF T-LYMPHOCYTES IN ACUTE REJECTION FOLLOWING VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | Received |
560-P | CHARACTERIZING B-LYMPHOCYTE MEDIATED REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | Received |
561-P | MINIMALLY AND NON-INVASIVE REJECTION MONITORING MODALITIES IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | Received |
565-P | OUTCOMES OF KIDNEY TRANSPLANTATIONS FROM DECEASED DONORS WITH ANURIC/OLIGURIC ACUTE KIDNEY INJURY | Cheol Woong Jung | Received |
566-P | THE PREDICTIVE VALUE OF AORTOILIAC CALCIFICATION OF DECEASED DONORS FOR CHRONICITY SCORE OF BIOPSIES AND GRAFT OUTCOMES IN KIDNEY TRANSPLANTATION | Cheol Woong Jung | Received |
567-P | SUCCESSFUL LUNG TRANSPLANTATION FROM HEPATITIS C VIREMIC DONORS IN CRITICALLY ILL RECIPIENTS | Jasleen Kukreja | Received |
569-P | UROLOGIC COMPLICATIONS IN OUR ORGAN TRANSPLANT UNIT AFFECTING RECIPIENTS FROM BRAID DEAD DONORS DURING THE LAST DECADE. | NIKOLAOS DIMITROKALLIS | Received |
570-P | BUBBLE AND INTERMITTENT SURFACE OXYGENATION ARE AN EFFECTIVE ALTERNATIVE FOR MEMBRANE-OXYGENATED HMP-KIDNEYS TO MAINTAIN AEROBIC METABOLISM. | Tom Darius | Received |
571-P | COMPARATIVE STUDY OF PATHOGENS AFFECTING OUR KIDNEY TRANSPLANT UNIT FOLLOWING CHANGE IN ANTIBIOTIC PROPHYLAXIS PROTOCOL DURING THE PERIOD 2010-2022. | Nikolaos Dimitrokallis | Received |
572-P | THROMBOTIC MICROANGIOPATHY AND EARLY HUMORAL REJECTION AFTER ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: A FRENCH MULTICENTER CASE-CONTROL STUDY. | BERTRAND Dominique | Received |
574-P | SOTROVIMAB AS PRE-EXPOSITION PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS: NEUTRALIZATION OF OMICRON BA.1 AND BA.2 VARIANTS | Roman Reindl-Schwaighofer | Received |
577-P | SPLIT RENAL FUNCTION, RENAL VASCULAR VARIATIONS AND DONOR PREFERENCES: CHALLENGE AND CROSSROADS TOWARDS RIGHT KIDNEY CHOICE | Zaklina Sterjova | Received |
578-P | NOVEL PROGNOSTIC MARKERS FOR LIVER CIRRHOSIS IN PATIENTS ON THE ROMANIAN WAITING LIST FOR LIVER TRANSPLANT | Speranta Iacob | Received |
580-P | RECOMBINANT SARS-COV-2-ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITHOUT NEUTRALIZING ANTIBODIES FOLLOWING FULL VACCINATION (RESCUE-TX) | Andreas Heinzel | Received |
582-P | MORTALITY OF THE CIRRHOTIC PATIENTS ON THE LIVER TRANSPLANT WAITING LIST DURING THE COVID-19 PANDEMIC | Girleanu Irina | Received |
583-P | PRETRANSPLANT EVALUATION OF LIVING KIDNEY DONORS AND RECIPIENTS: FROM THEPERSPECTIVE OF THE TRANSPLANT COORDINATORS. | Xanthi Sarantzi | Received |
585-P | HLA MOLECULAR MISMATCH AND HLA-SPECIFIC MEMORY B CELLS BEFORE AND AFTER KIDNEY TRANSPLANTATION IN FEMALE CANDIDATES SENSITIZED BY PREGNANCIES | Sara Sanz-Ureńa | Received |
586-P | COMPARISON OF THE IMPACT OF NORMOTHERMIC AND HYPOTHERMIC PRESERVATION METHODS ON KIDNEY LIPIDOMIC PROFILE USING SPME CHEMICAL BIOPSY | Natalia Warmuzinska | Received |
587-P | MEDIA COVERAGE OF PATIENTS WAITING FOR A TRANSPLANT INFLUENCES HEALTHCARE WORKERS IN AN UNPREDICTABLE WAY, BUT NOT THE SOCIETY | Francisca Gonzalez Cohens | Received |
588-P | LUMINEX SINGLE ANTIGEN ASSAY ON 1:10 DILUTED SERUM PREDICTS THE DROP IN ANTI-HLA ANTIBODIES BEFORE DESENSITIZATION OR TREATMENT OF HUMORAL REJECTION | Dominique Bertrand | Received |
589-P | REENGINEERING, THE TOOL THAT CAN REVOLUTIONIZE ORGAN PROCUREMENT IN CHILE | Francisca Gonzalez Cohens | Received |
591-P | ORGAN DONATION A CROSS-SECTIONAL SURVEY AMONG MEDICAL STUDENTS IN ROMANIA | Girleanu Irina | Received |
592-P | PANCREATIC ISLET CONDITIONING FOR TRANSPLANTATION BY RNA INTERFERENCE | Jan Kriz | Received |
593-P | PREGNANCY INDUCED SENSITISATION AND HLA-ANTIBODY INCOMPATIBLE KIDNEY TRANSPLANTATION (HLA-AIT): NOT ALL IS BAD NEWS FOR LONG TERM GRAFT SURVIVAL. | Sunil Daga | Received |
594-P | ADULT KIDNEY TRANSPLANT RECIPIENTS AT RISK OF CMV INFECTION AND DISEASE: AN OBSERVATIONAL STUDY | Gerrit Burger | Received |
595-P | ASSOCIATION OF BODY COMPOSITION WITH PRESENCE OF SUBCLINICAL TARGET ORGAN DAMAGE IN KIDNEY TRANSPLANT RECIPIENTS. | Marilena Kylla | Received |
597-P | BENEFIT OF LIVING DONOR LIVER TRANSPLANTATION IN GRAFT SURVIVAL FOR EXTREMELY HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE = 35 | Sang Oh Yun | Received |
598-P | REDUCED FRAILTY AND IMPROVED FUNCTIONAL CAPACITY IN EXERCISING LIVER TRANSPLANT CANDIDATES | Ilias Marios Oikonomou | Received |
600-P | EXPERIENCE OF LIVER TRANSPLANTATION IN NATIONAL SCIENTIFIC CENTER FOR SURGERY NAMED AFTER A.N. SYZGANOV | Bolatbek Baimakhanov | Received |
601-P | REVISED CRITERIA FOR DIASTOLIC DYSFUNCTION OF CIRRHOTIC CARDIOMYOPATHY AND MAJOR ADVERSE CARDIAC EVENTS AFTER LIVER TRANSPLANT. | Jeayoun Kim | Received |
602-P | NEW NON-INVASIVE MARKERS OF PORTAL HYPERFLOW AND ITS ROLE IN CIRRHOSIS AND POST-LIVER TRANSPLANT OUTCOME | Luca Del prete | Received |
604-P | SARS-COV-2 SUBGENOMIC RNA IN KIDNEY TRANSPLANT RECIPIENTS. UTILITY IN PROGNOSIS OF PATIENTS WHO HAVE RECEIVED REMDESIVIR. | Judit Cacho | Received |
605-P | LIVER AUTO-TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS TO DEFINE INDICATIONS AND DETERMINE SURVIVAL | Eleonora Nieddu | Received |
606-P | NUCLEIC ACID TESTING TO FACILIATE KIDNEY TRANSPLANTATION FROM INCREASED-INFECTIOUS RISK DECEASED DONORS: CLINICAL OUTCOMES AND VIRAL TRANSMISSION RISK | Laura Kenny | Received |
607-P | COMPARING OUTCOMES OF FIRST AND SECOND DECEASED DONOR KIDNEY TRANSPLANTATION: A RETROSPECTIVE STUDY | Sunghyo An | Received |
608-P | ASSOCIATION BETWEEN BODY COMPOSITION AND ANKLE-BRACHIAL INDEX IN KIDNEY TRANSPLANT RECIPIENTS. | Maria Perdikouli | Received |
609-P | THE EARLY ALLOGRAFT FAILURE SIMPLIFIED ESTIMATION SCORE OUTPERFORMS CLASSIC OLTHOFF EAD IN PREDICTING 90-DAY GRAFT LOSS IN DCD LIVER TRANSPLANTATION | Femke de Goeij | Received |
610-P | OUTCOME OF PATIENTS WITH C3 GLOMERULONEPHRITIS AFTER LIVING DONOR KIDNEY TRANSPLANTATION | Christina Melexopoulou | Received |
611-P | EPRO DIARY LIVER: A NEW WAY TO PROMOTE PATIENT COMPLIANCE AND MORE | Luisa Pasulo | Received |
612-P | Immunosuppression non-adherence in kidney transplant patients: a comparison between short-term (1 year post-transplant), long-term (3 years post-transplant) and patients with a failing graft (GFR 20mL/min) | Rosie Heape | Received |
613-P | ASSOCIATION BETWEEN PHENOTYPES OF BLOOD PRESSURE CONTROL AND BODY COMPOSITION IN KIDNEY TRANSPLANT RECIPIENTS. | Theodora Penna | Received |
615-P | BK VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS UNDERGOING REGULAR SCREENING | Daniel Bräuner Rasmussen | Received |
616-P | DISEASE COURSE, MANAGEMENT AND OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS WITH SARS COV2 INFECTION DURING THE OMICRON WAVE: A SINGLE-CENTER EXPERIENCE. | Kalliopi Vallianou | Received |
618-P | EARLY OUTCOMES OF LIVER TRANSPLANTS AFTER NORMOTHERMIC MACHINE PERFUSION | Ioannis D. Kostakis | Received |
620-P | PHOSPHATIDYLETHANOL AS A MARKER FOR THE DIAGNOSIS OF ALCOHOL RELAPSE AFTER LIVER TRANSPLANTATION: SINGLE CENTRE EXPERIENCE | Svetlana Adamcova Selcanova | Received |
621-P | ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO PREDICT FUNCTIONAL OUTCOME OF THE ARTERIOVENOUS FISTULAE IN A PATIENTS WITH END-STAGE RENAL FAILURE | Mahmoud Mohamed Tolba | Received |
623-P | LIVER TRANSPLANTATION FOR ECSTASY INDUCED FULMINANT HEPATIC FAILURE: THE NEED FOR GUIDELINES. | Stavros Neiros | Received |
624-P | ASSOCIATION OF VESSEL-SPECIFIC CORONARY ARTERY STENOSIS WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RENAL TRANSPLANT CANDIDATE COHORT | Bing Jie Chow | Received |
625-P | NORMOTHERMIC REGIONAL PERFUSION REDUCES APOPTOSIS MARKERS IN CONTROLLED DONATION AFTER DETERMINATION OF DEATH | Gabriel Moreno-Gonzalez | Received |
626-P | PEDIATRIC LUNG TRANSPLANTATION ON EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT WITH PERIPHERAL CANNULATION: A SINGLE CENTER EXPERIENCE | Arianna Trizzino | Received |
627-P | LONG TERM EFFECTS OF COMPOSITE WARM AND COLD ISCHAEMIC TIME IN DECEASED DONOR KIDNEY TRANSPLANTATION | Muhammad Khurram | Received |
628-P | 30 YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: AN APPRECIATION OF ITS SURVIVAL BENEFIT OVER KIDNEY TRANSPLANTATION ALONE | Elisabet Van Loon | Received |
630-P | LEFT LOBE LIVER VOLUME CALCULATION USING REALITY CAPTURE HARDWARE VIA LIGHT DETECTION AND RANGING (LIDAR) 3D TECHNOLOGY | Konstantina Eleni Karakasi | Received |
631-P | TOWARDS THE DEVELOPMENT OF A REGIONAL PEDIATRIC DCD NETWORK MODEL: A PREPARATORY SURVEY | Maria Adele Figini | Received |
632-P | EFFECT ON HUMORAL SENSITIZATION OF DUAL TARGETING APPROACH WITH ANTI-CD38 MAB AND COSTIMULATION BLOCKADE IN HIGHLY SENSITIZED PATIENTS (COMBAT STUDY) | Delphine Kervella | Received |
633-P | DUAL INDUCTION WITH ANTI-THYMOCYTE GLOBULIN AND RITUXIMAB IN SENSITIZED KIDNEY TRANSPLANT PATIENTS. | Joon Heon Jeong | Received |
634-P | DE NOVO UPPER TRACT UROTHELIAL CARCINOMA AFTER RENAL TRANSPLANTATION | Jian Zhang | Received |
636-P | A NOVEL APPROACH TO ADDRESS MASS MEDIA CAMPAIGNS FOR ORGAN DONATION PROMOTION. THE REGIONAL EXPERIENCE OF A 5-MILION INHABITANTS AREA OF ITALY. | Giuseppe Feltrin | Received |
638-P | VOLUMETRIC ASSESSMENT OF HEPATIC GRAFTS USING LIGHT DETECTION AND RANGING (LIDAR )TECHNOLOGY | Konstantina Eleni Karakasi | Received |
639-P | SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN OLDER RECIPIENTS | Pooja Budhiraja | Received |
641-P | POST-TRANSPLANT DONOR SPECIFIC ANTIBODIES DYNAMICS CAN BE PREDICTED USING C3D ASSAY IN ASSESSMENT FOR HLA-INCOMPATIBLE KIDNEY TRANSPLANTATION | Sunil Daga | Received |
642-P | LATE NON-CATHETER-RELATED VENOUS THROMBOTIC EVENTS IN LUNG TRANSPLANT RECIPIENTS | Ivan Barone | Received |
643-P | DONATION AFTER CIRCULATORY DEATH IN INTESTINAL TRANSPLANTATION: THE PATH TO PROVE ITS VALIDITY IN BOTH EXPERIMENTAL AND CLINICAL MODELS | Javier Serradilla | Received |
644-P | TRANSPLANT RENAL ARTERY STENOSIS SURGICAL INTERVENTION: TIME IS GFR | Gozde Gultekin | Received |
645-P | THE IMPACT OF LIVE KIDNEY DONATION IN A KIDNEY EXCHANGE PROGRAMME ON THE HEALTH-RELATED QUALITY OF LIFE OF THE DONOR. | Stijn van de Laar | Received |
646-P | LIVING DONOR NEPHRECTOMY: COMPARISON OF LEARNING CURVES AND SURGICAL OUTCOMES OF ROBOTIC VS LAPAROSCOPIC TECHNIQUE FROM TWO EUROPEAN CENTERS | Leonardo Centonze | Received |
647-P | TRENDS AND COST OF HEART TRANSPLANTATION AND VENTRICULAR ASSIST DEVICES IN GREECE-A LOW ORGAN DONATION ENVIRONMENT. | Angeliki Gkouziouta | Received |
648-P | LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: DIFFERENCES IN PRE-TRANSPLANT RADIOLOGY VERSUS EXPLANT PATHOLOGY REPORTS AND IMPACT ON SURVIVAL | Ahmed Sherif | Received |
650-P | REVIEWING CARDIAC STRESS TESTING AS PART OF KIDNEY TRANSPLANTATION WORK-UP | Ashveer Randhay | Received |
651-P | Post-Transplant Lymphoproliferative Disorder: A Focus On Outcomes in Living-Donor and Extended-Criteria Kidney Recipients | Mehmet Ergisi | Received |
652-P | Evaluation of a Bead-Based non-HLA Antibody Detection Assay in Male Blood Donors Demonstrates Values up to 10x Cut-Off | Amogh Agrawal | Received |
653-P | PREDICTION OF GRAFT SURVIVAL PRIOR TO ACCEPTING AN OFFER FOR DECEASED DONOR KIDNEY TRANSPLANT: AN ARTIFICIAL INTELLIGENCE APPROACH | Hatem Ali | Received |
654-P | AVAILABILITY OF PRE-DONATION CLINICAL DATA AND OUTCOMES OF KIDNEY TRANSPLANT ALLOGRAFTS FROM DECEASED DIABETIC DONORS. | Anna Buxeda | Received |
655-P | EVALUATION OF KIDNEY DONOR RISK INDEX / KIDNEY DONOR PROFILE INDEX AS PREDICTOR TOOLS OF DECEASED-DONOR KIDNEY TRANSPLANT OUTCOMES IN A GREEK COHORT | Maria Darema | Received |
657-P | THE FALL OF A MYTH: THE FIRST THREE CASES OF DONATION AFTER CIRCULATORY DEATH IN INTESTINAL TRANSPLANTATION | Javier Serradilla | Received |
658-P | PREFORMED DONOR-SPECIFIC ANTIBODIES IN DECEASED-DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER STUDY | Ioannis Michelakis | Received |
659-P | IMPLEMENTATION OF NEW M-HEALTH TOOL TO MONITOR IMMUNOSUPPRESSION ADHERENCE AND VITAL PARAMETERS IN KIDNEY TRANSPLANT PATIENTS | Valme Rodriguez | Received |
660-P | GENE EXPRESSION PROFILES OF PERITUBULAR CAPILLARITS IN CHRONIC ANTIBODY-MEDIATED REJECTION | Michael Eder | Received |
662-P | TRANSPLANTATION OF EXTENDED CRITERIA DECEASED DONOR KIDNEYS TO EXTENDED CRITERIA RECIPIENTS: A CHALLENGING COHORT | HAITHAM SOLIMAN | Received |
663-P | PREEMPTIVE KIDNEY TRANSPLANTATION: EXPANDING TO ALL KIND OF DONORS AND RECEPTOR | Javier Arias Alcalá | Received |
664-P | DECEASED ORGAN DONATION ACTIVITY, IN THE CRITICAL CARE UNIT OF A GREEK UNIVERSITY HOSPITAL, DURING 2022 | FRANTZESKA FRANTZESKAKI | Received |
665-P | LONG TERM OUTCOMES OF COMBINED LIVER KIDNEY TRANSPLANTATION | Conor Hennessy | Received |
666-P | ESTIMATING TIME TO LIVER TRANSPLANTATION USING PROGNOSIS SCORES IN PATIENTS WITH LARGE-DUCT PRIMARY SCLEROSING CHOLANGITIS | Speranta Iacob | Received |
668-P | EVALUATING THE BIDIRECTIONAL IMPACT OF KIDNEY TRANSPLANTATION AND HIV CONTROL | Fatima Ali | Received |
669-P | EPH RECEPTOR SIGNALLING AND CELL MIGRATION IN 3 D CELL CULTURES THROUGH EPHRIN MIMETIC PEPTIDES | Aiste Gulla | Received |
670-P | CHRONIC ALLOGRAFT NEPHROPATHY IS AGGRAVATED IN AGED DONORS BY THE EXACERBATION OF AGE-RELATED LOSS OF PROTECTIVE FACTORS | Elisenda Banon-Maneus | Received |
671-P | MI-EDON STUDY: THE ROLE OF RESPIRATORY PHYSIOTHERAPY AS TOOLS FOR THE OPTIMIZATION OF THE LUNG DONOR. | Alberto Sandiumenge | Received |
672-P | LAPAROSCOPIC LIVE DONOR NEPHRECTOMY AND VASCULAR ANATOMICAL VARIATIONS: A CHALLENGE FOR THE TRANSPLANT SURGEON. | Dionysios Prevezanos | Received |
673-P | READMISSIONS TO KIDNEY TRANSPLANTATION DEPARTMENT: INCIDENCE, CAUSES AND RISK FACTORS | tlili syrine | Received |
674-P | MEDIAN ARCUATE LIGAMENT COMPRESSION-AN ACHILLEAS KNEE FOR HEPATIC ARTERY FLOW DURING LIVER TRANSPLANTATION | Cristian Lupascu | Received |
675-P | PHOTOPROTECTION AND SKIN CANCER AWARENESS IN KIDNEY TRANSPLANT RECIPIENTS LIVING WITH HIV: A SINGLE-CENTRE CROSS-SECTIONAL STUDY | Fatima Ali | Received |
676-P | THE DEVELOPMENT OF REJECTION IS ASSOCIATED WITH A MORE AGGRESSIVE PATTERN OF POSTTRANSPLANT NEOPLASIA | Elena Cuadrado-Payán | Received |
677-P | BEST PRACTICES ALONG THE KIDNEY TRANSPLANTATION CLINICAL JOURNEY: A QUANTITATIVE SURVEY TOOL | Sara Machado | Received |
678-P | 3D BIOPRINTING OF A BIONIC PANCREAS WITH A VASCULAR SYSTEM RESULTS OF TRANSPLANTATION IN LARGE ANIMALS. | Michal Wszola | Received |
679-P | THE BURDEN OF SKIN DISEASE IN KIDNEY TRANSPLANT RECIPIENTS LIVING WITH HIV: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS | Fatima Ali | Received |
680-P | KIDNEY TRANSPLANTATION IN ALBANIA: A SINGLE CENTER EXPERIENCE | Elvana Rista | Received |
681-P | VALGANCICLOVIR PROPHYLAXIS IN HIGH-RISK TRANSPLANT RECIPIENTS: A DOUBLE-EDGED SWORD WITH IMPLICATIONS FOR NEUTROPENIA AND KIDNEY GRAFT SURVIVAL | Fabian Halleck | Received |
682-P | GLOBAL BURDEN OF CYTOMEGALOVIRUS RESISTANCE TO ANTIVIRALS IN FRANCE | Sophie Alain | Received |
684-P | INPATIENT REHABILITATION AFTER LIVER TRANSPLANTATION IN A DEDICATED REHABILITATION HOSPITAL IS FEASIBLE, SAFE, AND EFFECTIVE. | Lydia Christoforidi | Received |
685-P | OUTCOME OF KIDNEY TRANSPLANTATION IN PATIENTS WITH BALKAN ENDEMIC NEPHROPATHY | Stela Zivcic-Cosic | Received |
687-P | THE STRUCTURE OF THE SYSTEM OF TRANSPLANT COORDINATORS IN POLAND. | Teresa Danek | Received |
689-P | INTRAPATIENT VARIABILITY AND TESTS ABOVE LOWER TACROLIMUS TRESHOLD ARE ASSOCIATED WITH ACUTE REJECTION IN PANCREAS TRANSPLANTATION | Diana Rodríguez-Espinosa | Received |
690-P | THE IMPACT OF SURGICAL SITE INFECTIONS (SSI) ON OUTCOME AFTER DECEASED DONOR LIVER TRANSPLANT | Femke de Goeij | Received |
691-P | NONCODINGRNA-BASED BIOMARKERS IN AFP NORMAL HEPATOCELLULAR CARCINOMA: LNCRNA SNGH1 PLAYS AN IMPORTANT ROLE IN RECURRENCE AFTER LIVER TRANSPLANTATION | Secil Ak Aksoy | Received |
693-P | PERI-TRANSPLANT DESENSITIZATION WITH APHERESIS AND RITUXIMAB IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED DONOR-SPECIFIC ANTIBODIES AND A NEGATIVE CDC CROSSMATCH. A SINGLE EXPERIENCE CENTRE. | Cinthia Carolina Baldallo Moreno | Received |
694-P | LONGITUDINAL ANALYSIS OF ANTIBODIES IMMUNE RESPONSES IN KIDNEY TRANSPLANT RECIPIENTS AFTER SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | Ana Pinho | Received |
695-P | LAPAROSCOPIC LIVE DONOR NEPHRECTOMY AND SIMULTANEOUS LAPAROSCOPIC OPERATIONS.EVOLUTION OF MINIMAL INVASIVE LIVE DONOR NEPHRECTOMY. | Apostolos Angelis | Received |
696-P | IMPACT OF DELAYED GRAFT FUNCTION COMBINATION WITH OTHER COMPLICATIONS ON LATE POSTTRANSPLANT OUTCOMES. | Janis Jushinskis | Received |
697-P | AFTER A STEPWISE METHODOLOGY TO SHAPE A NATIONAL ALLOCATION SCORING SYSTEM FOR LIVER TRANSPLANTATION, WHICH IS THE BEST METRICS TO EVALUATE RESULTS? | Silvia Trapani | Received |
698-P | A SINGLE CELL TRANSCRIPTOMIC LANDSCAPE OF KIDNEY ENDOTHELIAL CELLS, FROM KIDNEY ORGANOIDS TO MATURE KIDNEY | Hector Tejeda Mora | Received |
700-P | ANTICOAGULANT AND ANTIPLATELET USE IN RENAL TRANSPLANTATION: IS PERIOPERATIVE BLOOD LOSS AND TRANSFUSION RATES A SIGNIFICANT CONCERN? | John Black | Received |
701-P | EVOLUTION OF MINIMAL INVASIVE LIVE DONOR NEPHRECTOMY:TECHNIQUES AND OUTCOMES FROM THE BUSIEST GREEK RENAL TRANSPLANT CENTER,IN LAIKO GENERAL HOSPITAL | Spyridon Vernadakis | Received |
702-P | WHEN MORE IS NOT BETTER BIG DATA AND MACHINE LEARNING IN ASSESSING THE RISK OF COVID-19 INFECTION IN SOT RECIPIENTS AND PATIENTS ON WAITING LIST | Dorota Kaminska | Received |
703-P | IMPACT OF HEPATIC VEIN RECONSTRUCTION TECHNIQUE ON VENOUS OUTFLOW OBSTRUCTION IN VENA-CAVA SPARING (PIGGYBACK) DECEASED DONOR LIVER TRANSPLANT | Gianna Fernandez | Received |
704-P | ROBOTIC SURGERY TO SOLVE URINARY TRACT COMPLICATIONS AFTER KIDNEY TRANSPLANTATION | Begońa Etcheverry Giadrosich | Received |
705-P | THE COMPASSIONATE MINDFUL RESILIENCE (CMR) PROGRAMME TO IMPROVE PSYCHOSOCIAL WELLBEING IN PEOPLE WITH KIDNEY DISEASE | Helen Noble | Received |
706-P | REAL-TIME ASSESSMENT OF PERFUSATE BIOMARKERS DURING EX SITU LIVER PERFUSION: A PILOT CLINICAL STUDY | Caterina Lonati | Received |
707-P | HEART TRANSPLANTATION IN RECIPIENTS OVER 60 YEARS-OLD: A SINGLE-CENTRE EXPERIENCE | Maria Simonenko | Received |
708-P | Sexual Dysfunction and Kidney Transplantation: A Scoping Review of Current Research | Clare Mckeaveney | Received |
709-P | STATE-OF-THE-ART LAPAROSCOPIC LIVE DONOR KIDNEY RETRIEVAL TWICE IN THE SAME PATIENT. A UNIQUE CASE IN THE WORLD LITERATURE. | Apostolos Angelis | Received |
710-P | TIMING OF PERITONEAL DIALYSIS CATHETER REMOVAL IN KIDNEY TRANSPLANT RECIPIENTS: A MULTICENTER PROPENSITY SCORE MATCHED COHORT STUDY | Piotr Domagala | Received |
711-P | SOCIAL TRENDS IN LIVING RENAL DONORS IN A SINGLE CENTER | tlili syrine | Received |
712-P | IMMUNOADSORPTION-BASED HLA DESENSITIZATION IN PATIENTS AWAITING DECEASED DONOR KIDNEY TRANSPLANTATION | Yosu LUQUE | Received |
713-P | NO ASSOCIATION BETWEEN ARTERIAL REPERFUSION TIME AND CLINICAL OUTCOMES FOR LIVER TRANSPLANTATION USING DONATION AFTER CIRCULATORY DEATH GRAFTS | Alessandro Parente | Received |
714-P | ADDED-VALUE OF RITUXIMAB AND PE ON TOP OF STANDARD INDUCTION THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED HIGH-TITER DSA | Yosu Luque | Received |
715-P | DECEASED DONOR LIVER TRANSPLANT (DDLT) WITH DUCT-TO-DUCT ANASTOMOSIS USING CONTINUOUS OR INTERRUPTED SUTURING, AND 5-0 OR 6-0 SUTURE SIZE | Gianna Fernandez | Received |
716-P | TACROLIMUS CONCENTRATION-TO-DOSE RATIO AND ITS ASSOCIATIONS WITH TACROLIMUS METABOLITES: PRELIMINARY ANALYSIS OF THE TIPS TRIAL | Thomas Jouve | Received |
717-P | PREDICTIVE OUTCOMES OF ACCEPTED AND DECLINED KIDNEY OFFERS: ARE WE DECLINING GOOD KIDNEYS ! | Mahmoud Mohamed Tolba | Received |
718-P | HEPATITIS B VIRUS REACTIVATION IN KIDNEY TRANSPLANT RECIPIENTS TREATED WITH BELATACEPT | Yosu Luque | Received |
726-P | IS THERE VALUE IN PROPHYLACTIC TREATMENT OF POST-TRANSPLANT RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS? A MULTICENTER RETROSPECTIVE STUDY. | Cyril GARROUSTE | Received |
727-P | PORTAL VEIN THROMBOSIS AND LIVER TRANSPLANTATION: OUR EXPERIENCE | Apostolos Angelis | Received |
728-P | PRE-TRANSPLANT MITOCHONDRIAL RESPIRATION IN HUMAN KIDNEY ALLOGRAFTS PREDICTS CLINICAL OUTCOME UPON TRANSPLANTATION | Andras T. Meszaros | Received |
729-P | EX-SITU SPLIT LIVER TRANSPLANTATION: A SAFE PARACHUTE PROCEDURE WHEN IN-SITU SPLITTING IS NOT POSSIBLE. | Zoe Larghi Laureiro | Received |
730-P | THE RING OF POWER -DIFFUSE SUB-EPICARDIAL LGE AS A NEW MARKER OF CARDIAC REJECTION IN HEART TRANSPLANT RECIPIENTS . | Angeliki Gkouziouta | Received |
731-P | ORAL SEMAGLUTIDE SAFETY IN KIDNEY TRANSPLANT RECIPIENTS WITH TYPE 2 DIABETES | Diana Rodríguez-Espinosa | Received |
732-P | EPIDEMIOLOGICAL AND CLINICAL CORRELATIONS BETWEEN ERECTILE DYSFUNCTION AND KIDNEY TRANSPLANT STATUS | Miron Adelina | Received |
734-P | INFLUENCE OF RENAL GRAFT FUNCTION IN PREGNANT WOMEN WHO UNDERWENT WITH KIDNEY TRANSPLANT | Cheng-Hsu Chen | Received |
735-P | ASSESSMENT OF EXTENDED CRITERIA DONOR LIVERS WITH INDOCYANINE GREEN DURING EX-VIVO MACHINE PERFUSION | Femke de Goeij | Received |
736-P | SHORT-TERM OUTCOME AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION WITH ALEMTUZUMAB VS. BASILIXIMAB INDUCTION; A SINGLE-CENTER RETROSPECTIVE STUDY | Tim Swaab | Received |
737-P | STABLE RECOVERY AFTER A MYOCARDITIS TREATED WITH CENTRAL ECMO AND IMPELLA: SHOULD WE DESIGN DIFFERENT ALLOCATION RULES FOR MYOCARDITIS? | Mario Passaro | Received |
738-P | KIDNEYS FROM UDCD WITH NRP SUPPORT VS KIDNEYS FROM BRAIN DEAD DONORS: A COMPARATIVE ANALYSIS OF TRANSPLANTATION OUTCOMES. | Ana Pinho | Received |
739-P | A RETROSPECTIVE OBSERVATIONAL STUDY ON THE DECLINING LIVER TRANSPLANT ASSESSMENT RATES AT EDINBURGH TRANSPLANT CENTRE | Ahmed Sherif | Received |
741-P | SHORT- AND LONGTERM OUTCOME IN LIVER TRANSPLANT RECIPIENTS WITH EARLY ALLOGRAFT DYSFUNCTION | Felix Oldhafer | Received |
742-P | TIXAGEVIMAB/CILGAVIMAB FOR PREVENTING SARS-COV-2 IN HEART TRANSPLANTED PATIENTS POOR VACCINE RESPONDERS: A HOPE OR YET ANOTHER GUY IN THE FIELD ? | Marco Masetti | Received |
743-P | CONTEMPORARY MANAGEMENT OF RENAL TRANSPLANT RECIPIENTS WITH DE NOVO URINARY STONES. A SINGLE INSTITUTION EXPERIENCE. | Maria Ramos-Cebrián | Received |
744-P | COVID-19 AND ACUTE PANCREATITIS IN KIDNEY TRANSPLANT RECIPIENTS | Danilo Radunovic | Received |
745-P | CLINICAL MANIFESTATIONS AND OUTCOMES OF CORONAVIRUS DISEASE-19 IN HEART TRANSPLANT RECIPIENTS. | Angeliki Gkouziouta | Received |
747-P | FIRST EXPERIENCE WITH COVID-19 VACCINATION IN HEART TRANSPLANT PATIENTS | Maria Simonenko | Received |
748-P | THE SERIOUS CONSEQUENCE OF DECREASE IMMUNOSSUPPRESSION AFTER COVID-19 IN A COHORT OF KIDNEY TRASPLANTATION | Javier Paul | Received |
749-P | ROLE OF CORONARY CALCIUM SCORE IN RULING OUT CORONARY ARTERY DISEASE AND IN WAITLIST PATIENTS SELECTION FOR LIVER TRANSPLANT CANDIDATES | Luigina Cocchiarella | Received |
752-P | A SINGLE CENTRE FIRST EXPERIENCE OF PAEDIATRIC HEART TRANSPLANTATION FROM ADULT DONORS | Maria Simonenko | Received |
754-P | A SINGLE-CENTRE EXPERIENCE OF COVID-19 MANAGEMENT IN HEART TRANSPLANT RECIPIENTS | Maria Simonenko | Received |
755-P | PRE-EXPOSURE PROPHYLAXIS WITH TIXAGEVIMAB/CILGAVIMAB IN A SLOVENIAN NATIONAL COHORT OF KIDNEY TRANSPLANT RECIPIENTS | pela Bortnar | Received |
756-P | ACUTE KIDNEY INJURY AFTER ALIROCUMAB APPLICATION IN A KIDNEY TRANSPLANT RECIPIENT WITH LUPUS NEPHRITIS A CASE REPORT | pela Bortnar | Received |
757-P | ROBOTIC VS LAPAROSCOPIC VS OPEN NEPHRECTOMY FOR LIVE KIDNEY DONATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROL TRIALS | Georgios Kourounis | Received |
758-P | NON HEART-BEATING DONOR PROGRAM FOR KIDNEY TRANSPLANTATION : FIVE YEAR RESULTS FROM A PORTUGUESE UNIT | Ines Aires | Received |
759-P | POST-TRANSPLANT DIABETES MELLITUS IN PEDIATRIC PATIENTS AFTER KIDNEY TRANSPLANTATION: INCIDENCE AND OUTCOMES. | Lina Maria Serna Higuita | Received |
760-P | CLINICAL IMPACT AND SAFETY OF ONE-YEAR DENOSUMAB THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH OSTEOPOROSIS | Woo Yeong Park | Received |
762-P | SAFETY AND EFFICACY OF GLP1-RAS AND ISGLT-2- COMPARED WITH THE STANDARD OF CARE IN A COHORT OF LIVER TRANSPLANTED PATIENTS: A RETROSPECTIVE STUDY | Alessandra Mazzola | Received |
764-P | CLINICAL AND MOLECULAR SPECTRUM OF V-LESION | Anna Buxeda | Received |
765-P | DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS | Anna Buxeda | Received |
766-P | CHARACTERISTICS OF PROSPECTIVE AND EFFECTIVE LIVING DONORS FOR RENAL TRANSPLANTATION: A CROSS-SECTIONAL STUDY. | Andrea Garcia Lopez | Received |
767-P | THE CRITICAL PATHWAY FOR DECEASED DONATION: AN ANALYSIS IN THREE REGIONS OF COLOMBIA | Andrea Garcia Lopez | Received |
17-20 September, Athens
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|